[
    {
        "src_smiles": "Cn1ccnc1SCC(=O)Nc1cccc([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a pyridine ring with a thioether linkage to an amide group which is attached to a nitro-substituted benzene ring.",
            "Property Analysis": "The QED property (Quantitative Estimate of Drug-likeness) of the source molecule is likely affected by the presence of the nitro group, which is generally considered undesirable in drug design due to potential toxicity and metabolic instability.",
            "Limitation in Source Molecule for Property": "The nitro group on the benzene ring is a major limiting factor for drug-likeness. Additionally, the overall molecular structure might lack adequate solubility or stability characteristics.",
            "Optimization for Source Molecule": "Replacing the nitro group with a less polar functional group, such as a halogen or a methoxy group, might improve the QED property by enhancing stability and reducing potential toxicity.",
            "Final Target Molecule": "Cn1ccnc1SCC(=O)Nc1cccc(Cl)c1"
        }
    },
    {
        "src_smiles": "O=C(O)c1cn(COCCO)c2ccc([N+](=O)[O-])cc2c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is N,N-dimethylnitrobenzamide with a benzene ring, two amide groups, a nitro group, and an ether linkage.",
            "Property Analysis": "The presence of polar and nitro groups may contribute to solubility but can affect metabolic stability and permeability, impacting QED.",
            "Limitation in Source Molecule for Property": "The nitro group can reduce the drug-likeness due to potential toxicity and poor ADMET properties. The dimethoxy side chain may also contribute to instability.",
            "Optimization for Source Molecule": "Consider replacing the nitro group with a less electron-withdrawing group and simplifying the ether linkage to improve metabolic stability and drug-likeness.",
            "Final Target Molecule": "O=C(O)c1ccncc1C1=CC=C(N)C=C1"
        }
    },
    {
        "src_smiles": "CCOC(=O)c1cnc2ccnn2c1SCC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an ester derivative with a thiazole fragment. It contains an ether group, an ester linkage, and a thioether group, with a pyrimidine heterocycle.",
            "Property Analysis": "The current molecule has moderate drug-likeness (QED) due to reasonable molecular weight and presence of heteroatoms and functional groups. However, it may have issues with polarity and lipophilicity.",
            "Limitation in Source Molecule for Property": "The presence of both ether and thioether groups can reduce lipophilicity, potentially affecting the molecule's ability to interact with biological targets efficiently. The aromatic system is also not extensively conjugated, which may limit favorable interactions.",
            "Optimization for Source Molecule": "Introduce additional hydrophobic groups or expand the aromatic system to enhance lipophilicity and improve interactions. Consider modifying the ester group to an amide to increase stability and drug-likeness.",
            "Final Target Molecule": "CCON(C)C(=O)c1cnc2cc(C)c(O)n2c1"
        }
    },
    {
        "src_smiles": "C=CCSc1cc(C)nc2c(-c3ccccc3)c(C)nn12",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a thienyl-substituted pyrimidine compound. It contains a thiophene group (C=CCS) attached to a pyrimidine core that is further substituted by phenyl and methyl groups.",
            "Property Analysis": "This molecule is relatively complex with potential aromatic ring interactions and moderate hydrophobicity due to phenyl and methyl groups, which may impact its drug-likeness (QED). Pyrimidines are often pharmacophores, and thiophene can provide aromatic stability.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings and sulfur atom increases molecular weight and hydrophobic character, potentially lowering QED. The distribution and redundancy of aromatic systems may not be optimal for balance between hydrophobic and hydrophilic regions.",
            "Optimization for Source Molecule": "To improve the QED (drug-likeness), consider simplifying the aromatic system for better solubility and reducing hydrophobicity. Removing or modifying the thiophene group while maintaining essential moieties for activity could enhance the balance between lipophilicity and aqueous solubility.",
            "Final Target Molecule": "CC1=NC2=CC=CN=C2N1C3=CC=CC=C3"
        }
    },
    {
        "src_smiles": "COCCSc1nnc(NC(=O)CSc2ccccc2)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a thiadiazole ring substituted with a methoxymethyl and a thioether moiety, along with an amide linkage to a phenylthio group.",
            "Property Analysis": "The molecule's QED (Quantitative Estimate of Drug-likeness) score can be influenced by its molecular weight, lipophilicity, and hydrogen bond donors and acceptors.",
            "Limitation in Source Molecule for Property": "The presence of heavy atoms and a potentially high lipophilicity due to the thioether and thiadiazole may reduce the QED score.",
            "Optimization for Source Molecule": "To improve QED, reduce molecular weight and lipophilicity by modifying or replacing heavy or large groups like the methoxymethyl and phenylthio moieties with smaller, less lipophilic groups that maintain biological activity.",
            "Final Target Molecule": "COCCSc1nnc(NC=O)cs1"
        }
    },
    {
        "src_smiles": "O=C1NC(=O)C(=Cc2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The molecule is an isothiazole derivative with a nitro group on an aromatic ring, indicating potential aromaticity and electronic interactions. It contains a lactam and an extended conjugated system.",
            "Property Analysis": "The source molecule has functional groups that contribute to rigidity and potential for electronic interactions, like the nitro group and the aromatic rings. These may affect the QED score due to possible toxicity or metabolic instability.",
            "Limitation in Source Molecule for Property": "The presence of a nitro group is often associated with reduced drug-likeness due to toxicity concerns. Additionally, the conjugated system may contribute to metabolic instability.",
            "Optimization for Source Molecule": "To increase QED, consider replacing the nitro group with a less toxic electron-withdrawing group like fluorine or chlorine, and potentially reducing the extent of conjugation.",
            "Final Target Molecule": "O=C1NC(=O)C(=Cc2ccc(-c3cccc(F)c3)o2)S1"
        }
    },
    {
        "src_smiles": "O=C(CCCCCCC(=O)Nc1ccccc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an amide, which includes a long aliphatic chain, an aromatic ring, and a hydroxamic acid group.",
            "Property Analysis": "The molecule has a moderate potential for drug-likeness but may suffer from issues related to high molecular weight and presence of potentially unstable hydroxamic acid.",
            "Limitation in Source Molecule for Property": "The long aliphatic chain increases lipophilicity and molecular size, reducing QED. The hydroxamic acid group is prone to metabolic instability.",
            "Optimization for Source Molecule": "Reduce the aliphatic chain length and replace the hydroxamic acid with a more stable functional group such as a carboxamide.",
            "Final Target Molecule": "O=C(NC1=CC=CC=C1)CCC(=O)N"
        }
    },
    {
        "src_smiles": "CON(C)C(NC(C)=O)C(=O)NCc1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is Acetamide, N,N-dimethyl-2-(phenylmethoxy)acetamide. It contains functional groups such as amides and an ether linkage. The phenyl group attached to the ether might contribute to its hydrophobic character.",
            "Property Analysis": "The QED (quantitative estimate of drug-likeness) property is a measure of a compound's similarity to known drugs in terms of physicochemical properties. Generally, lower molecular weight, appropriate balance of hydrophilic and lipophilic properties, and the presence of hydrogen bond acceptors/donors tend to enhance the QED score.",
            "Limitation in Source Molecule for Property": "The presence of multiple amide groups and a phenyl ring may increase the molecular weight and hydrophobic character, which might limit the QED score. Additionally, steric hindrance due to the dimethyl amide substitution could potentially interfere with optimal receptor binding.",
            "Optimization for Source Molecule": "To improve drug-likeness, consider reducing molecular weight and tuning hydrophobicity by removing excess methyl groups and potentially replacing or modifying the phenyl ring to enhance solubility and reduce steric hindrance.",
            "Final Target Molecule": "COC(=O)NC(C)Nc1ccccc1"
        }
    },
    {
        "src_smiles": "O=C(C=Cc1ccc(C(=O)c2ccc3ccccc3n2)cc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is composed of a central oxime group (O=C(C=Cc1ccc(C(=O)c2ccc3ccccc3n2)cc1)NO) linking two aromatic rings. The structure includes a naphthyridine moiety and a separate ketone linkage.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) of a molecule is influenced by multiple factors including Lipinski's Rule of Five, flexibility, and polar surface area. Aromatic rings contribute positively to QED but large, rigid structures and the presence of polar unbalanced moieties like the oxime group can adversely affect it.",
            "Limitation in Source Molecule for Property": "The oxime group might introduce an unfavorable polar point that doesn't fit well with a drug-likeness profile. Moreover, the presence of multiple conjugated rings may contribute rigidity, potentially negatively impacting the drug-likeness score.",
            "Optimization for Source Molecule": "To improve the QED, reducing complexity and balancing polarity is key. Consider replacing the oxime group with a less polar yet similar-sized group such as an ether or ester. Additionally, simplifying or adjusting the naphthyridine moiety to reduce steric hindrance could be beneficial.",
            "Final Target Molecule": "O=C(C=CC1=CC=C(C=C1)C(=O)C2=CC=C3C=CC=CN23)O"
        }
    },
    {
        "src_smiles": "O=C(O)CN1C(=O)SC(=Cc2cccc([N+](=O)[O-])c2)C1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is characterized by a bicyclic system comprising a lactam ring and a thiazole ring. It contains a nitro-substituted phenyl group and a terminal carboxylic acid group attached via an amide linkage.",
            "Property Analysis": "The QED (Quantitative Estimation of Drug-likeness) score evaluates several factors such as molecular weight, lipophilicity (logP), solubility, polarity, and the presence of toxicophores. The molecule has several functional groups like nitro and carboxylic acid, affecting its drug-likeness negatively.",
            "Limitation in Source Molecule for Property": "The presence of a nitro group can reduce the QED score due to its potential toxicity. Additionally, multiple carbonyl groups and polar functionalities may impact lipophilicity and membrane permeability.",
            "Optimization for Source Molecule": "To optimize for a better QED score, a rational modification involves removing or substituting the nitro group with less electron-withdrawing or less polar substituents. One could also consider reducing polar functionalities, possibly replacing one carbonyl group with a less polar group like an ether.",
            "Final Target Molecule": "O=C(O)CN1C(=O)SC(=Cc2ccc(O)c2)C1=O"
        }
    },
    {
        "src_smiles": "O=C(CCCc1ccc(CCCCc2ccccc2)cc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an aromatic ketone with a benzene ring substituted with a carboxamide group. It also contains a long alkyl chain connecting to another benzene ring.",
            "Property Analysis": "The current structure might exhibit low QED due to the large, lipophilic alkyl chains and limited polar functionality, which affects solubility and permeability.",
            "Limitation in Source Molecule for Property": "The molecule's large hydrophobic chains and lack of diversity in functional groups can limit its drug-likeness property, as it may affect absorption and distribution characteristics.",
            "Optimization for Source Molecule": "Introduce polar functional groups or heteroatoms to increase hydrogen bonding potential and improve solubility. Consider reducing the length of alkyl chains or replacing them with more polar groups.",
            "Final Target Molecule": "O=C(CCCc1ccc(cc1)OCCc2ccc(Cl)cc2)NO"
        }
    },
    {
        "src_smiles": "C#CCCCC(=O)c1cc2c(c(C(C)(C)C)c1)OCC2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a linear aliphatic chain containing an alkyne group, a ketone functional group, and a bicyclic aromatic moiety with a t-butyl group attached.",
            "Property Analysis": "The molecule exhibits some characteristics of drug-likeness, such as a bicyclic structure and the presence of a t-butyl group, which may enhance lipophilicity. However, it may present drawbacks due to potential instability of the alkyne and limited hydrogen bonding sites.",
            "Limitation in Source Molecule for Property": "The presence of an alkyne may reduce metabolic stability, and the lack of hydrogen bond donors can affect solubility and permeability, lowering the overall QED score.",
            "Optimization for Source Molecule": "Converting the alkyne to a more stable functional group like an alkene or fully saturated alkane can improve stability. Introducing a heteroatom such as nitrogen or oxygen in the aliphatic chain or modifying the existing ketone to an amide to increase hydrogen bonding potential could enhance the QED.",
            "Final Target Molecule": "C=CCCCC(=O)N(C)Cc1cc2c(c(C(C)(C)C)c1)OCC2"
        }
    },
    {
        "src_smiles": "CN(c1ccc(C=CC(=O)NO)cc1)S(=O)(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a sulfonamide derivative with a methylamino group attached to a benzene ring, which is itself connected to another benzene ring through a sulfonyl group.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) is a metric considering factors like lipophilicity, molecular weight, solubility, and the presence of specific functional groups.",
            "Limitation in Source Molecule for Property": "The presence of the sulfonyl group and the amide may increase molecular weight and polarity, potentially affecting drug-likeness negatively.",
            "Optimization for Source Molecule": "To improve QED, reduce the molecular weight and optimize hydrophobic/hydrophilic balance, possibly by modifying bulky groups like sulfonyl to smaller ones or replacing the amide with less polar groups.",
            "Final Target Molecule": "CN(c1ccc(C=C)cc1)Cc1ccccc1"
        }
    },
    {
        "src_smiles": "O=C(NC(=S)NCc1ccco1)c1ccc([N+](=O)[O-])cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an amide with a thiourea functionality and an aromatic nitro compound. It consists of a benzonitrile core with a nitro group and a heteroaromatic furan ring connected through an alkyl linker.",
            "Property Analysis": "The source molecule contains a furan ring which adds aromatic character, and an electron-withdrawing nitro group which may impact electron distribution and reactivity. Its functional groups include amide and thiourea, which are common in bioactive molecules. However, the molecule's complexity and potential for electronic instability may affect its drug-likeness.",
            "Limitation in Source Molecule for Property": "The presence of a polar, electron-withdrawing nitro group may lead to reduced membrane permeability. Additionally, the thiourea moiety can be metabolically unstable, and the overall molecular complexity may affect synthetic accessibility and drug-likeness. The combination of these elements could lower the QED score.",
            "Optimization for Source Molecule": "To improve the QED property, consider reducing the electron-withdrawing effects by replacing the nitro group with a less polar substituent such as a methoxy group. Additionally, replacing the thiourea linkage with a more stable moiety such as an ether or amine could help improve stability and solubility.",
            "Final Target Molecule": "O=C(NCc1ccco1)c1cccc(OCC)c1"
        }
    },
    {
        "src_smiles": "CSc1nccc(C#Cc2ccc(CC(C)NC(C)=O)cc2)n1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a thiomethyl-substituted pyrimidine ring attached to a phenylpropenamide group, with a secondary amine in the side chain.",
            "Property Analysis": "QED (Quantitative Estimate of Drug-likeness) is a composite property that evaluates the drug-likeness of a molecule based on factors like molecular weight, lipophilicity, and the presence of undesirable functionalities.",
            "Limitation in Source Molecule for Property": "The presence of a thiomethyl group and an acetylene linkage might impact lipophilicity and metabolic stability negatively, affecting the overall QED.",
            "Optimization for Source Molecule": "To improve QED, consider replacing the thiomethyl group with a more metabolically stable and less lipophilic group such as a fluorine, and modifying the alkyne to a more stable alkene to improve the overall drug-likeness profile.",
            "Final Target Molecule": "Fc1nccc(C=Cc2ccc(CC(C)NC(C)=O)cc2)n1"
        }
    },
    {
        "src_smiles": "COc1ccc(C(=O)Nc2cccc(OC(=O)c3ccco3)c2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an aromatic amide with methoxy and ester functional groups. It contains a benzene ring linked via an amide bond to another benzene ring, which is substituted with a furan moiety through an ester linkage.",
            "Property Analysis": "The source molecule exhibits potential drug-like properties such as aromaticity and functional groups amenable to hydrogen bonding and hydrophobic interactions, which are favorable for biological activity.",
            "Limitation in Source Molecule for Property": "The presence of multiple polar functional groups such as the amide and ester may increase the molecular polarity, potentially affecting membrane permeability. Additionally, the molecule might have high molecular weight, which could limit oral bioavailability.",
            "Optimization for Source Molecule": "To optimize for drug-likeness, consider reducing molecular weight and polarity. One approach is to replace the methoxy group with a smaller substituent such as a fluorine atom to decrease the molecular descriptor profile without significantly impacting activity. Alternatively, simplify the ester linkage to reduce polarity.",
            "Final Target Molecule": "COc1ccc(C(=O)Nc2cccc(F)c2)cc1"
        }
    },
    {
        "src_smiles": "CN(CC(=O)Nc1ccc(S(N)(=O)=O)cc1)C(=N)N",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an amide with potential sulfonamide and amidine functionality. It contains a secondary amine, a benzene ring substituted with a sulfonamide group, and an amidine functionality.",
            "Property Analysis": "The presence of a sulfonamide group may contribute positively to drug-likeness, while the amidine group might reduce it due to basicity. The entire molecule may have potential solubility issues related to its polar functionalities.",
            "Limitation in Source Molecule for Property": "The primary limitation in terms of drug-likeness (QED) could be the amidine moiety, which is quite basic and may affect oral bioavailability negatively. Additionally, excessive polarity from sulfonamide and amidine could hinder the compound's ability to permeate cell membranes.",
            "Optimization for Source Molecule": "Reduce basicity by modifying the amidine group to a more neutral amide or urea linkage. Consider simplifying the sulfonamide group or reducing its size to decrease potential polarity issues.",
            "Final Target Molecule": "CN(CC(=O)Nc1ccc(S(=O)(=O)N)cc1)C(=O)N"
        }
    },
    {
        "src_smiles": "CCCCCCOc1ccc(C(=O)CCN2CCCCC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an ether with an aromatic ring and a ketone group, along with a piperidine moiety. The n-hexyl chain provides lipophilicity, while the aromatic ring and amide are important for interactions.",
            "Property Analysis": "The molecule possesses an aromatic ring which is generally favorable for drug-likeness. However, the lipophilicity might be high due to the n-hexyl chain, and the molecular weight could be bordering the upper limits affecting solubility and permeability.",
            "Limitation in Source Molecule for Property": "The long n-hexyl chain might increase lipophilicity excessively, affecting the drug-like properties negatively. Additionally, the overall molecular weight might limit drug-likeness.",
            "Optimization for Source Molecule": "Reduce the aliphatic chain length to balance the log P value and manage molecular weight. Consider replacing the n-hexyl with a butyl group to retain some lipophilicity but reduce excessive weight and improve solubility.",
            "Final Target Molecule": "CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1"
        }
    },
    {
        "src_smiles": "CC(=O)NC(=Cc1ccc2c(c1)OCO2)C(=O)NCCCO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex amide featuring a phenolic ether ring system (chromene) and multiple amide functionalities. The presence of multiple carbonyl (C=O) and ether (O-C-O) groups indicates diverse functional groups.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) score evaluates the drug-likeness of molecules based on properties like molecular weight, logP, presence of functional groups, and topological polar surface area. The source molecule has moderate drug-likeness due to its considerable size and polar functional groups.",
            "Limitation in Source Molecule for Property": "The size and lipophilicity due to the chromene structure and hydrocarbon chains may influence solubility and membrane permeability, affecting its QED score negatively. The polar groups increase the topological polar surface area, which can impede passive diffusion.",
            "Optimization for Source Molecule": "To improve QED, simplify the structure by reducing size, or converting large aromatic systems possibly by removing or replacing hydrophobic groups. Introducing balanced polarity could optimize membrane permeability and drug-likeness.",
            "Final Target Molecule": "CC(=O)NC=1Cc2ccccc2O1"
        }
    },
    {
        "src_smiles": "CC(=O)NCC1CN(c2ccc(C(C)=NO)cc2)C(=O)O1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an aryl-substituted cyclic amide with a nitrile substituent on the phenyl ring, as well as an ester group. It contains a piperidine ring linked to a phenyl group, which carries an oxime group.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) property considers drug-like features such as molecular weight, lipophilicity, polar surface area, and the presence of specific substructures. The presence of multiple functional groups like the ester and nitrile might impact the lipophilicity and solubility parameters.",
            "Limitation in Source Molecule for Property": "The ester group may reduce metabolic stability, while the nitrile group could affect the solubility adversely. These factors could limit the QED score due to their effects on the drug-likeness profile.",
            "Optimization for Source Molecule": "Remove or modify the ester group to enhance metabolic stability. Replace the nitrile group with a less polar group to potentially improve solubility and enhance drug-likeness.",
            "Final Target Molecule": "CCNCC1CN(c2ccc(O)cc2)C(=O)O1"
        }
    },
    {
        "src_smiles": "CC(=NO)c1ccc(N2C(=O)C3CC=C(Cl)CC3C2=O)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an oxime derivative attached to a bicyclic structure with two carbonyl groups. It contains a chlorine-substituted cyclohexene ring and an aromatic ring.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) property is influenced by molecular properties including lipophilicity, molecular weight, solubility, and the presence of drug-like functional groups.",
            "Limitation in Source Molecule for Property": "The presence of the chlorine atom may increase lipophilicity and potentially reduce solubility. Additionally, the bicyclic structure with two carbonyl groups might increase molecular rigidity, affecting drug-likeness.",
            "Optimization for Source Molecule": "To optimize, consider reducing the lipophilicity by removing or replacing the chlorine atom with a more polar group, such as hydroxyl or methoxy, to enhance solubility. Modifying the bicyclic system to include more flexible linkages may also improve drug-likeness.",
            "Final Target Molecule": "CC(=NO)c1ccc(N2C=O)cc1"
        }
    },
    {
        "src_smiles": "CCSCCSc1nnc(-c2ccc([N+](=O)[O-])cc2)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a thiadiazole with an aromatic nitro group attached. It contains sulfide linkages and a nitrobenzene moiety.",
            "Property Analysis": "The presence of the nitro group might negatively impact the QED due to potential toxicity and metabolic instability. The sulfide linkages could also affect the drug-likeness due to their susceptibility to oxidation.",
            "Limitation in Source Molecule for Property": "The nitro group is a structural alert for drug-likeness, and the sulfur linkages can pose stability issues.",
            "Optimization for Source Molecule": "Replacing the nitro group with a less reactive and more drug-like substituent such as a trifluoromethyl (-CF3) group could improve the QED. Additionally, reducing the number of sulfide linkages or replacing them with ether linkages might improve stability and overall drug-likeness.",
            "Final Target Molecule": "CCOCCOc1nnc(-c2ccc(CF3)cc2)s1"
        }
    },
    {
        "src_smiles": "O=C(O)C=Cc1cn(Cc2ccc([N+](=O)[O-])cc2)c2ccccc12",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule includes an acrylate moiety, a nitro-substituted aromatic ring linked to a pyrrole, and an extended conjugated system.",
            "Property Analysis": "The QED property (quantitative estimation of drug-likeness) is influenced by the presence of reactive groups, molecular weight, and lipophilicity. The nitro group may adversely affect drug-likeness due to potential toxicity and electronic effects.",
            "Limitation in Source Molecule for Property": "The nitro group is detrimental to the QED property due to its electronic nature and potential for forming toxic metabolites. The acrylate group can also be reactive, posing challenges for drug stability.",
            "Optimization for Source Molecule": "To improve the QED, replace the nitro group with a less electron-withdrawing and non-toxic group, such as a methoxy group. This will reduce the polarity and improve stability. Additionally, replacing the acrylate moiety with a less reactive ester or amide can also enhance drug-likeness without significantly increasing molecular weight.",
            "Final Target Molecule": "O=C(NC)C=Cc1cn(Cc2ccc(OC)cc2)c2ccccc12"
        }
    },
    {
        "src_smiles": "COc1ccc2c(CSCCBr)cc(=O)oc2c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is identified with a methoxybenzofuran structure that is substituted with a sulfide-linked bromoethyl group. It contains aromatic rings, ether groups, sulfide linkage, bromine, and a furanone moiety.",
            "Property Analysis": "The quantitative estimate of drug-likeness (QED) is calculated based on criteria such as molecular weight, lipophilicity (LogP), topological polar surface area (TPSA), number of hydrogen bond donors and acceptors, and presence of unwanted functional groups.",
            "Limitation in Source Molecule for Property": "The presence of a bromine atom and a sulfide bridge can affect the drug-likeness score by reducing solubility and potentially increasing toxicity. The relatively large and flexible side chain may also negatively impact the molecule's bioavailability and efficacy due to reduced binding efficiency.",
            "Optimization for Source Molecule": "To improve the QED, consider removing or replacing the bromine with smaller, more electronegative atoms like fluorine. The sulfide bridge can be replaced with an ether or direct alkyl linkage to reduce size and improve solubility. Keeping or enhancing the aromatic and oxygen-containing functional groups can maintain or improve pharmacophore compatibility.",
            "Final Target Molecule": "COc1ccc2c(COCCF)cc(=O)oc2c1"
        }
    },
    {
        "src_smiles": "O=C(OCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)C1CCCN1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a carbamate derivative with a nitro-substituted phenyl ring attached to a 1,2,4-triazole moiety, further linked to a piperidine ring. Its SMILES is O=C(OCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)C1CCCN1.",
            "Property Analysis": "Quantitative Estimate of Drug-likeness (QED) is a measure of the drug-likeness of a compound, taking into account factors like molecular weight, lipophilicity, solubility, and the presence of toxic or reactive substructures.",
            "Limitation in Source Molecule for Property": "The presence of a nitro group can negatively impact drug-likeness due to its potential toxicity and metabolic instability. Additionally, the molecular weight and lipophilicity need to be balanced.",
            "Optimization for Source Molecule": "To improve the QED score, the nitro group can be replaced with a less toxic and more stable functional group such as a fluorine or chlorine. Additionally, adjusting the linker or alkyl side chains could reduce overall molecular weight and modify the lipophilicity, leading to a better drug-likeness score.",
            "Final Target Molecule": "O=C(OCc1cn(-c2ccc(F)cc2)nn1)C1CCCN1"
        }
    },
    {
        "src_smiles": "COc1ccc(CCNC(=O)CSc2nncn2N)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is 2-methoxy-5-(2-(methylamino)ethyl)phenol containing an aromatic ring, ether, and amide groups.",
            "Property Analysis": "The source molecule has moderate drug-likeness with fair logP values due to aromatic and polar groups but may have issues with solubility and metabolism.",
            "Limitation in Source Molecule for Property": "Presence of ether linkages and lack of diversity in functional groups might lower drug-likeness. The aromatic moiety provides stability, but additional optimization could improve solubility and metabolic stability.",
            "Optimization for Source Molecule": "Introduce a polar functional group, like hydroxyl, to enhance solubility. Replace ether groups with alkyl chains to improve metabolic stability.",
            "Final Target Molecule": "COc1ccc(CCNCCO)cc1OC"
        }
    },
    {
        "src_smiles": "C#CCCCOc1ccc2c(C)cc(=O)oc2c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an acetophenone derivative with a phenoxy group and a terminal alkyne chain. The molecule contains aromatic rings, ether, and ketone functional groups.",
            "Property Analysis": "The source molecule has potential for drug-likeness with its aromatic rings contributing to hydrophobic interactions and the ether/ketone functionalities offering potential sites for hydrogen bonding.",
            "Limitation in Source Molecule for Property": "The presence of a terminal alkyne may reduce the water solubility and the size of the aromatic system is relatively large which might affect the overall balance of hydrophobicity and hydrophilicity.",
            "Optimization for Source Molecule": "To improve QED, consider modifying the alkyne to a more polar functional group, and reducing the size of the aromatic system while retaining essential aromaticity. Introducing a common drug-like moiety such as a pyridine ring could improve water solubility.",
            "Final Target Molecule": "c1cc(C(=O)CO)nc(c1)COC"
        }
    },
    {
        "src_smiles": "C#CCOCC(Cn1cncn1)c1ccc(Cl)cc1Cl",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule has a propargyl alcohol group, an ether linkage, a substituted piperazine moiety, and a dichlorobenzene ring. These features contribute to its complexity and potential interactions, but may also affect drug-likeness.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) is a measure combining several molecular properties including molecular weight, lipophilicity, and the number of hydrogen bond donors and acceptors. High QED is associated with balanced properties ideal for oral drugs.",
            "Limitation in Source Molecule for Property": "The present molecule contains a triple bond, multiple chlorines, and possibly excessive molecular weight and lipophilicity that may reduce its QED score.",
            "Optimization for Source Molecule": "To improve drug-likeness, we can consider reducing the number of halogens, replacing the triple bond with a suitable functional group, and evaluating the ether linkage's chemical space.",
            "Final Target Molecule": "CCCOCC(Cn1cncn1)c1ccccc1"
        }
    },
    {
        "src_smiles": "CCc1ccc(OC(C)=O)c(C(=O)c2ccc(C)cc2)c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an acetophenone derivative with two phenyl rings and ester functionality. It features ethyl group substitutions at meta and para positions, and is characterized by two carbonyl groups, one as a ketone and the other as an ester.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) is influenced by molecular weight, hydrogen bond donors/acceptors, logP, and polar surface area. The presence of the ester and ketone groups contribute to polar characteristics, while the two phenyl groups and alkyl substitutions impact lipophilicity.",
            "Limitation in Source Molecule for Property": "The primary limitation is the potential for high molecular weight and logP due to multiple aromatic rings and the ester group, potentially affecting solubility and permeability, key factors in QED.",
            "Optimization for Source Molecule": "To improve QED, the strategy could involve reducing molecular weight or lipophilicity by modifying the alkyl chains or reducing aromatic system abundance, such as by converting the ester group into an amide to balance polarity and reduce size.",
            "Final Target Molecule": "CCc1ccc(NC(C)=O)c(C(=O)c2ccc(C)cc2)c1"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c2c(ncn2C)n(C)c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is 1,3-Dimethylxanthine, which belongs to the xanthine class of compounds. It contains a purine ring system with two ketone functionalities and is often associated with derivatives related to caffeine and theobromine.",
            "Property Analysis": "The molecular structure suggests moderate hydrophilicity due to the presence of polar carbonyl groups, which can interact favorably with water molecules. The methyl groups contribute to slight lipophilicity. The molecular weight is relatively low, and the compact structure may aid bioavailability.",
            "Limitation in Source Molecule for Property": "The primary limitations regarding drug-likeness and QED (Quantitative Estimate of Drug-likeness) could be related to a balance between hydrophilicity and lipophilicity. Additionally, the presence of entirely polar functional groups without any substantial hydrophobic moiety limits its membrane permeability.",
            "Optimization for Source Molecule": "To enhance QED, introducing a hydrophobic group like an alkyl or phenyl group could increase membrane permeability while maintaining balance with polar groups. This would enhance interaction with biological targets and potentially improve the bioavailability and drug-likeness profile.",
            "Final Target Molecule": "Cn1c(=O)c2c(ncn2C)n(C)c1C(C)C"
        }
    },
    {
        "src_smiles": "Nc1ccc(C=CC(=O)Nc2cccc(Cl)c2)cc1O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a phenolic amine linked to an anilide group via an enone moiety. The molecular structure includes potential polar functional groups such as an amine, a hydroxyl group, an enone, and a chloro-substituted benzene ring.",
            "Property Analysis": "This molecule may already possess some drug-like properties, given its polar functionalities and aromatic structures, which are often seen in pharmaceutical compounds. The presence of hydrogen bond donors (NH2, OH) and an acceptor (C=O) may be beneficial for interactions with biological targets.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic systems and the polar functional groups enhance the drug-likeness, but the chlorine atom might contribute to increased lipophilicity and potential toxicity. Additionally, the enone linkage might pose stability issues or lead to metabolic liabilities.",
            "Optimization for Source Molecule": "To improve drug-likeness, consider replacing the chloro group with a less lipophilic substituent like a methoxy or methyl group, improving stability by changing the enone linkage to an amide or removing it, and ensuring functional groups remain that are capable of forming hydrogen bonds.",
            "Final Target Molecule": "Nc1ccc(C(=O)NCC)c(O)c1"
        }
    },
    {
        "src_smiles": "Cc1cn(C2CC(NC(=O)CC(=O)O)C(CO)O2)c(=O)[nH]c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a bicyclic compound with a pyrimidinone core. It includes a lactam ring fused with a morpholine ring, and has multiple functional groups including a methyl group, hydroxyl groups, carboxylic acid, and ketones.",
            "Property Analysis": "The molecule has multiple polar functional groups which may potentially interfere with lipophilicity and membrane permeability. These are important factors influencing the drug-likeness or QED score of the molecule.",
            "Limitation in Source Molecule for Property": "The hydroxyl and carboxyl groups may reduce the lipophilicity. The presence of the ketones and the multiple nitrogen atoms may also affect the electron distribution and the overall drug-likeness of the molecule without significantly contributing positively to the QED score.",
            "Optimization for Source Molecule": "Consider reducing the number of polar groups, such as methoxy or ester modifications to the alcohol and carboxylic acid. Simplifying the structure to maintain or improve lipophilicity while retaining essential pharmacophoric features can enhance QED.",
            "Final Target Molecule": "Cc1cn(C2CC(NC(=O)CC(=O)OC)C(C)O2)c(=O)n(c1)C"
        }
    },
    {
        "src_smiles": "CC(N)C(NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex structure featuring an amide bond and a terminal alkyne phenyl group. It possesses functional groups including secondary amine, amide, nitrile, and nitroxyl.",
            "Property Analysis": "The source molecule features diverse groups likely contributing to interactions with biological targets. However, its structural complexity might affect oral bioavailability and metabolic stability.",
            "Limitation in Source Molecule for Property": "The presence of a highly polar nitroxyl group and bulky alkyne group may compromise the QED by reducing bioavailability and increasing metabolic degradation risk.",
            "Optimization for Source Molecule": "Reducing molecular size and lipophilicity by removing or replacing the alkyne phenyl group, and converting the nitroxyl group to a less polar moiety can potentially improve the QED.",
            "Final Target Molecule": "CC(N)C(NC(=O)c1ccc(NC)cc1)C(=O)O"
        }
    },
    {
        "src_smiles": "CN=C(NC#N)NCCn1nc(-c2ccccc2)ccc1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a triazine core with substituents including a cyano group and a phenyl ring connected to the heterocycle, which suggests potential aromatic interactions. The molecule also contains a secondary amine and an aliphatic chain with a nitrile group.",
            "Property Analysis": "Quantitative Estimate of Drug-likeness (QED) is influenced by factors including molecular weight, hydrophobicity and polarity, hydrogen bond donors and acceptors, and presence of undesirable functionalities. The given molecule has a QED that appears moderate due to its functional groups and aromatic content.",
            "Limitation in Source Molecule for Property": "The presence of a cyano group and highly polarizable urea moiety may contribute negatively to the QED score due to increased polarity and potential reactivity. The molecule might also benefit from enhanced metabolic stability and balanced lipophilicity.",
            "Optimization for Source Molecule": "To improve the QED property, consider removing or reducing the impact of the cyano group to decrease excessive polarity, possibly by replacing it with a less polar group. Additionally, the urea moiety could be replaced with a more stable group that retains hydrogen bonding potential yet reduces overall polarity.",
            "Final Target Molecule": "CN=C(NC)NCCn1nc(-c2ccccc2)ccc1=O"
        }
    },
    {
        "src_smiles": "CC(N)C(NC(=O)c1ccc(C#Cc2ccccc2)cc1)C(=O)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an amide with a nitrile and an isoxazole group, alongside a secondary amine group attached to the main carbon chain. The presence of an aromatic system suggests potential stability but also requires consideration for polar and hydrophobic balance.",
            "Property Analysis": "The presence of multiple functional groups such as the amide, nitrile, and aromatic ring suggest moderate to high polarity and potential for hydrogen bonding, needed for good drug-likeness. However, these groups may also compete for interactions, negatively impacting solubility or bioavailability.",
            "Limitation in Source Molecule for Property": "The potential limitation for QED improvement lies in the steric hindrance and potential low solubility from the extended hydrophobic regions without compensatory polar functional groups enhancing water interaction.",
            "Optimization for Source Molecule": "To improve QED, minor structure modifications such as the addition of polar groups (e.g., hydroxyl groups), reduction of molecular weight by removing non-essential hydrophobic components, or improving symmetry for better interaction potential may be beneficial. Modifying the benzyl group or attaching a solubilizing group could also enhance drug-likeness.",
            "Final Target Molecule": "CC(N)C(NC(=O)c1ccc(OCC)cc1)C(=O)NO"
        }
    },
    {
        "src_smiles": "COc1nc(OCC(=N)NO)nc(N2CCOCC2)n1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a substituted purine derivative featuring a methoxy group, an oxime moiety, and a morpholine ring. Its structure suggests potential hydrogen bonding through the oxime, with additional polar interactions possible due to the ether and amine functionalities.",
            "Property Analysis": "The molecular structure suggests moderate flexibility with potential hydrogen bonding and polar interactions, which can impart drug-like properties. However, the overall flexibility and presence of ether linkages may compromise metabolic stability.",
            "Limitation in Source Molecule for Property": "The presence of multiple polar functional groups and potential for rotatable bonds could impact its metabolic stability and membrane permeability, affecting the QED property.",
            "Optimization for Source Molecule": "To enhance drug-likeness, specifically focusing on improving membrane permeability and metabolic stability, consider cyclizing the flexible portions or reducing the number of ether linkages while maintaining the hydrophilicity necessary for biological activity.",
            "Final Target Molecule": "Cn1c2c(ncnc2n(c1=O)C3CCNCC3)OC"
        }
    },
    {
        "src_smiles": "Cc1nc(C#Cc2cnc(SC(C)(C)C)nc2)cs1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a thiazole derivative containing alkenyl and thioether groups. It features a 1,3-thiazole ring with a cyanoethenyl group and a 1,3,5-triazine ring attached via a sulfur atom.",
            "Property Analysis": "Quantitative Estimate of Drug-likeness (QED) is a metric used to evaluate the potential of a compound as a drug based on its structural features and physicochemical properties.",
            "Limitation in Source Molecule for Property": "The presence of a cyano group and bulky tert-butyl group may decrease the drug-likeness due to potential issues with solubility, permeability, and potential reactivity.",
            "Optimization for Source Molecule": "To improve QED, consider replacing the cyanoethenyl group with a simpler alkyl or aryl group to reduce size and polarity. Also, replace the tert-butyl group with a smaller alkyl group to improve overall molecule compactness.",
            "Final Target Molecule": "Cc1nc(Cc2cccnc2)cs1"
        }
    },
    {
        "src_smiles": "C[N+]([O-])=Cc1ccc2c(c1)OCO2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a nitroso group attached to a methyl group and a phenol fused with a dioxolane ring, suggesting potential issues with stability and interaction with biological targets.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) score may be affected by the polar nature of the nitroso group, which could impact lipophilicity and bioavailability.",
            "Limitation in Source Molecule for Property": "The nitroso group can lead to decreased membrane permeability and possible reactivity-related toxicity. The aromatic structure enhances stability but may lead to metabolic liabilities.",
            "Optimization for Source Molecule": "Consider reducing the polar nitroso group to a less polar form, such as an amine or methoxy group, to potentially improve lipophilicity and minimize reactivity.",
            "Final Target Molecule": "COCCc1ccc2c(c1)OCO2"
        }
    },
    {
        "src_smiles": "NC(=NO)c1ccc(C=Cc2ccc(O)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is comprised of a pyrimidine ring connected to a phenyl ring via an acrylic linker. The pyrimidine is substituted with an oxime and an amine group, while the phenyl ring has a hydroxyl group.",
            "Property Analysis": "The QED (Quantitative Estimation of Drug-likeness) score evaluates structural features, molecular weight, solubility, and synthetical accessibility. The current structure is planar with potential issues in solubility and bioavailability due to polar groups and aromaticity.",
            "Limitation in Source Molecule for Property": "The presence of polar and potentially reactive groups like oxime and hydroxyl limit the lipophilicity and may affect the membrane permeability, impacting QED negatively.",
            "Optimization for Source Molecule": "To improve QED, reducing the number of polar groups and increasing lipophilicity could be beneficial. Converting the oxime to a methyl group and protecting the phenolic OH group or converting it to an ether could enhance drug-likeness.",
            "Final Target Molecule": "CC(=O)c1ccc(C=Cc2ccc(OC)cc2)cc1"
        }
    },
    {
        "src_smiles": "Nc1ccccc1-c1cc(=O)c2ccc3ccccc3c2o1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is described by the SMILES string Nc1ccccc1-c1cc(=O)c2ccc3ccccc3c2o1. This compound includes an aniline moiety linked to a chromenone system. It consists of aromatic rings and an amine functional group.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) property evaluates the drug-likeness of a compound based on balance between physicochemical properties such as lipophilicity, molecular weight, and hydrogen bonding capacity. The source molecule may have moderate drug-likeness due to its aromaticity and potential binding interactions.",
            "Limitation in Source Molecule for Property": "The presence of a carbonyl group attached to aromatic rings might affect the solubility and rigidity of the structure, impacting overall bioavailability negatively. The drug-likeness could be limited by its high aromatic content and presence of the bulky chromenone structure.",
            "Optimization for Source Molecule": "To optimize for QED, we can reduce the aromaticity and seek to introduce more flexible linkers or replace certain aromatic groups with less rigid or more hydrophilic groups, such as alkyl chains or hydroxyl groups, to improve lipophilicity, solubility, and overall drug-like properties.",
            "Final Target Molecule": "Nc1ccc(O)cc1-c1ccc2c(c1)ccc(=O)o2"
        }
    },
    {
        "src_smiles": "NS(=O)(=O)c1ccc(NC(=S)NC(=O)c2cccc([N+](=O)[O-])c2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a sulfonamide with a thioamide and nitrobenzene moieties. The structure includes a sulfonamide group attached to an aniline ring, which is further linked to a thioamide group connected to a nitro-substituted benzene ring.",
            "Property Analysis": "The molecule has functional groups such as sulfonamide and nitro, which can have an impact on the compound's solubility, metabolism, and reactivity. The introduction of an electron-withdrawing nitro group may affect the compound's stability and drug-likeness.",
            "Limitation in Source Molecule for Property": "The presence of the nitro group can decrease the overall QED score due to its potential toxicity and impact on the metabolic stability. Additionally, thioamide groups are less common in drug-like molecules due to potential metabolic liabilities.",
            "Optimization for Source Molecule": "To optimize the QED, we could replace the nitro group with a less toxic electron-withdrawing group and consider modifying the thioamide linkage to improve overall stability and drug-likeness. Replacing the nitro group with a fluorine atom and the thioamide with a simple amide may improve the molecule's properties.",
            "Final Target Molecule": "NS(=O)(=O)c1ccc(NC(=O)NC(=O)c2ccccc2F)cc1"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccccc1)N1CCN(Cc2ccc(C=Cc3ccccc3)cc2)CC1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a urea derivative with a phenyl ring, a piperdine moiety, and a styrene group. It contains aromatic rings and a tertiary amine which are typical features for increasing drug-likeness.",
            "Property Analysis": "The source molecule is expected to have moderate QED due to the presence of aromatic systems, tertiary amine, and a potential for hydrophobic interactions.",
            "Limitation in Source Molecule for Property": "The styrenyl group might increase lipophilicity excessively, which can negatively impact solubility and overall QED. Additionally, the tertiary nitrogen may raise basicity, potentially reducing membrane permeability.",
            "Optimization for Source Molecule": "To improve QED, reduce lipophilicity and increase solubility by replacing the styrene moiety with a less hydrophobic group and introduce a polar substituent portion in the piperazine ring or adjacent areas.",
            "Final Target Molecule": "O=C(Nc1ccccc1)N1CCN(Cc2ccc(cc2)OC)CC1"
        }
    },
    {
        "src_smiles": "O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1cccc([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex aromatic compound, consisting of a benzene ring with a nitro group and an amide linking an indole derivative.",
            "Property Analysis": "The molecule is likely to have moderate to low QED due to its high aromaticity and the presence of a nitro group, which can affect solubility and permeability negatively.",
            "Limitation in Source Molecule for Property": "The nitro group and high rigidity of the aromatic rings can reduce drug-likeness. These features often lead to poor solubility and metabolic stability.",
            "Optimization for Source Molecule": "Replace the nitro group with a less polar and more metabolically stable group like a methoxy group. Consider reducing aromaticity by introducing aliphatic linkers or small heterocycles to improve flexibility and solubility.",
            "Final Target Molecule": "O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1ccc(OC)cc1"
        }
    },
    {
        "src_smiles": "Cc1c(Cc2cccc([N+](=O)[O-])c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a substituted naphthalene with nitro and ester groups, as well as a methoxy-carbonylated amine group.",
            "Property Analysis": "The QED (quantitative estimate of drug-likeness) is a property that assesses compounds on various factors including hydrophobicity, molecular weight, and presence of structural alerts.",
            "Limitation in Source Molecule for Property": "The presence of a nitro group often negatively affects the drug-likeness due to potential toxicity and metabolic stability issues. Additionally, the overall molecular weight and possible steric hindrance may impact its drug-like properties.",
            "Optimization for Source Molecule": "To improve the QED, the nitro group can be replaced with a less reactive and safer group, such as a cyano (nitrile) group, and the ester group can be simplified or replaced by a hydroxyl group to reduce molecular weight and enhance water solubility.",
            "Final Target Molecule": "Cc1c(Cc2cccc(c2)C#N)c(=O)oc2cc(O)ccc12"
        }
    },
    {
        "src_smiles": "O=C(COC(=O)c1ccccc1)Nc1ccc(Cl)cc1C(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex structure with amide, ester, and ketone functional groups along with chlorine substituents. It includes multiple aromatic rings, contributing to its stability and lipophilicity.",
            "Property Analysis": "The molecule likely possesses moderate drug-likeness due to its aromatic structure and presence of hydrogen bond donors and acceptors. However, its high molecular weight and multiple carbonyl groups might limit solubility and permeability.",
            "Limitation in Source Molecule for Property": "The large size and the presence of multiple aromatic rings may lead to low aqueous solubility. The two carbonyl groups directly linked to benzene rings can also make the molecule overly lipophilic.",
            "Optimization for Source Molecule": "To improve QED, reduce molecular weight and improve solubility by replacing one of the aromatic rings with a cycloalkyl group and removing a carbonyl group. This will reduce lipophilicity and molecular complexity.",
            "Final Target Molecule": "O=C(COC)c1ccc(Cl)cc1C"
        }
    },
    {
        "src_smiles": "Cn1cnc2cc(-c3ccc(C(=N)NO)cc3)nc(N3CCC(CO)C3)c2c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a substituted purine derivative with a morpholine-like amine substituent and an amidine oxime functionality.",
            "Property Analysis": "The QED property (Quantitative Estimate of Drug-likeness) measures the potential of a compound to be a viable drug based on molecular weight, lipophilicity, polarity, and other factors.",
            "Limitation in Source Molecule for Property": "The presence of a potential amidine oxime at one end and a secondary amine at the other might impact drug-likeness due to potential instability or undesirable interactions.",
            "Optimization for Source Molecule": "To improve drug-likeness, consider simplifying the polar groups like converting oxime to a ketone and minimizing the number of potential hydrogen bond donors/acceptors.",
            "Final Target Molecule": "Cn1cnc2cc(-c3ccc(C(N)=O)cc3)nc(N3CCCOC3)c2c1=O"
        }
    },
    {
        "src_smiles": "COCCSc1nnc(NC(=O)CCS(=O)(=O)Cc2ccccc2)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a sulfonamide derivative with an ether functional group and a substituted pyrazole ring. It consists of a phenyl group attached to the sulfonamide chain, which may contribute to its lipophilicity.",
            "Property Analysis": "The QED property, or Quantitative Estimate of Drug-likeness, is high when the molecule has good balance in molecular weight, logP, number of hydrogen bond donors and acceptors, and other factors. The aromatic character and presence of heteroatoms can contribute to this property, but excessive functional diversity and size can reduce QED.",
            "Limitation in Source Molecule for Property": "The sulfonamide group and ether linkage may increase the molecule's polarity, potentially reducing its drug-likeness unless well-balanced by hydrophobic regions. Additionally, the size and complexity of the molecule could limit QED due to potential steric and solubility issues.",
            "Optimization for Source Molecule": "To improve QED, simplify the structure to reduce steric bulk and examine replacing or modifying the sulfonamide linkage to control polarity. Consider removing non-essential aromatic substitutions to decrease molecular weight and logP without affecting potency.",
            "Final Target Molecule": "COCSc1nnc(NC(=O)C)s1"
        }
    },
    {
        "src_smiles": "O=C(CSc1ncccn1)Nc1ccc(S(=O)(=O)N2CCCCC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a benzene ring with a sulfonamide group attached, which is linked to a pyridine-like heterocycle via a thioester bond. It contains functional groups such as a carbonyl, sulfonamide, and a pyridine nitrogen.",
            "Property Analysis": "The molecule is likely to have moderate drug-likeness due to the presence of the aromatic ring and heterocycles which can contribute to binding interactions. However, the thioester linkage might reduce stability, and the molecule might have high molecular weight.",
            "Limitation in Source Molecule for Property": "The thioester bond may be unstable in biological environments, and the molecular weight is potentially near the upper limit for optimal drug-like properties, which could affect bioavailability.",
            "Optimization for Source Molecule": "To improve QED, consider replacing the thioester bond with a more stable amide or carbonyl linkage and possibly reducing the size of the cycloalkane linked to the sulfonamide to decrease molecular weight.",
            "Final Target Molecule": "O=C(CNc1ncccn1)Nc1ccc(S(=O)(=O)N2CCCC2)cc1"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1)c1cccc([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a sulfonamide derivative with a nitrobenzamide functional group. The structure consists of a sulfonamide linkage attached to an aniline ring, which in turn is connected to a benzoyl group with a nitro substituent.",
            "Property Analysis": "The QED property, or quantitative estimate of drug-likeness, is influenced by factors such as molecular weight, logP, number of hydrogen bond donors and acceptors, and presence of certain structural features. Sulfonamides can sometimes have solubility issues and the nitro group might affect metabolic stability.",
            "Limitation in Source Molecule for Property": "The presence of a nitro group may adversely affect the drug-likeness due to potential toxicity and metabolic liabilities. The overall molecular weight and logP need to be balanced for better solubility and permeability.",
            "Optimization for Source Molecule": "To enhance QED, consider substituting the nitro group with a less problematic electron-withdrawing group like a fluorine or trifluoromethyl which can reduce potential toxicity and improve metabolic stability. Additionally, introducing substituents that improve solubility, such as hydroxyl or small alkyl groups, can be beneficial.",
            "Final Target Molecule": "O=C(Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1)c1ccc(F)c1"
        }
    },
    {
        "src_smiles": "CCC(=O)Oc1ccc(NC(=O)c2ccc(S(=O)(=O)N3CCCC3)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an ester derivative with an aromatic ring system. It has functional groups such as amide, sulfonamide, and ester, which are common in drug-like molecules.",
            "Property Analysis": "The quantitative estimate of drug-likeness (QED) evaluates properties like molecular weight, lipophilicity, hydrogen bond donors and acceptors, and polar surface area. The source molecule likely has a moderate QED due to its complex structure but might be improved by addressing its solubility and permeability.",
            "Limitation in Source Molecule for Property": "The presence of the sulfonamide and ester groups may affect lipophilicity and metabolic stability. The molecular weight and potentially high lipophilicity due to multiple rings and functional groups might be limiting factors for QED.",
            "Optimization for Source Molecule": "To improve QED, reduce molecular weight and enhance lipophilicity. Consider removing or replacing bulky groups with simpler ones and optimizing hydrogen bond acceptors and donors.",
            "Final Target Molecule": "CC(=O)Nc1ccc(S(=O)(=O)C)cc1"
        }
    },
    {
        "src_smiles": "O=C(CCCC1CCN(S(=O)(=O)c2ccc3c(c2)CCO3)CC1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a sulfonamide derivative with a cyclic amine and a morpholine ring. It contains functional groups like amide, sulfone, and ether, which are common in drug molecules.",
            "Property Analysis": "The QED (quantitative estimate of drug-likeness) score evaluates how well the molecule fits the profile of known oral drugs. Factors include molecular weight, lipophilicity (LogP), topological polar surface area (TPSA), and the presence of structural alerts.",
            "Limitation in Source Molecule for Property": "The molecule may suffer from high TPSA and possibly suboptimal LogP, which can affect drug-likeness if it is too polar or not lipophilic enough. The bulky sulfonyl group might also contribute to lower drug-likeness in some contexts.",
            "Optimization for Source Molecule": "To improve QED, consider reducing the TPSA by modifying or removing polar groups such as the sulfone. Reducing the overall molecular weight by simplifying the structure can also be beneficial. Consider replacing the morpholine with a smaller nitrogen-containing ring to maintain amine characteristics while reducing bulk.",
            "Final Target Molecule": "O=C(CCCC1CCN(CC1)C2=CN=CS2)NO"
        }
    },
    {
        "src_smiles": "O=C(CCCCCCc1ccccc1)c1ncc(-c2cc([N+](=O)[O-])ccn2)o1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an oxazole derivative with a nitroarene moiety and a chain of carbon atoms connecting the benzene ring to the oxazole.",
            "Property Analysis": "The inclusion of nitro groups and the relatively large lipophilic chain may negatively impact the overall drug-likeness and QED score due to potential issues with solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The nitro group can reduce drug-likeness due to potential mutagenicity and the bulky hydrophobic chain may increase lipophilicity beyond optimal limits.",
            "Optimization for Source Molecule": "Replace the nitro group with a less reactive electron-withdrawing group like fluorine to maintain electronic effects while reducing potential toxicity. Consider shortening the aliphatic chain or adding polar substituents to improve solubility and QED.",
            "Final Target Molecule": "O=C(CCCCc1ccccc1)c1ncc(-c2cc(F)ccn2)o1"
        }
    },
    {
        "src_smiles": "CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2cccnc21",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a pyridine ring, a pyrimidine ring, a substituted benzoate ester, and a morpholine substituent with various functional groups including a nitro group.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) score gauges how drug-like a compound is, incorporating factors like molecular weight, logP, number of hydrogen bond donors and acceptors, polar surface area, and number of rotatable bonds.",
            "Limitation in Source Molecule for Property": "The presence of the nitro group (often associated with toxicity) and the molecular complexity with high rotatable bonds may negatively impact the QED.",
            "Optimization for Source Molecule": "To improve the drug-likeness, consider reducing the rotatable bond count and replacing the nitro group with a less polar and less potentially harmful group such as a cyano or methyl group. Simplifying the structure by removing or replacing extraneous substituents could potentially help in enhancing the QED.",
            "Final Target Molecule": "CCN1c2ncc(COc3ccccc3)cc2C(=O)N(C)c2cccnc21"
        }
    },
    {
        "src_smiles": "COc1ccc(C(=O)Nc2ccccc2-c2nc3ncccc3[nH]2)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an aromatic compound with a methoxy group on each of the aromatic rings and consists of a benzamide linked to a fused heteroaromatic system.",
            "Property Analysis": "The QED (quantitative estimation of drug-likeness) score is affected by factors such as molecular weight, lipophilicity, solubility, and structural complexity.",
            "Limitation in Source Molecule for Property": "The presence of two methoxy groups and a fused aromatic heterocyclic structure may increase molecular complexity and lipophilicity, potentially reducing QED score.",
            "Optimization for Source Molecule": "To improve drug-likeness, one might consider reducing molecular weight and lipophilicity by either removing or replacing one of the methoxy groups with a less lipophilic group.",
            "Final Target Molecule": "COc1ccc(C(=O)Nc2ccccc2-c2nc3[nH]cccc3n2)cc1C"
        }
    },
    {
        "src_smiles": "CN(C)CCCn1c(N)c(-c2nc3ccccc3s2)c2nc(C#N)c(C#N)nc21",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a 1,3,5-triazine core with cyano groups and an additional aromatic thiophene-like ring. It also includes a dimethylamino alkyl chain and a bicyclic aromatic moiety.",
            "Property Analysis": "QED (Quantitative Estimate of Drug-likeness) is an approach used to evaluate the 'drug-likeness' of a compound based on properties such as molecular weight, lipophilicity, solubility, and the presence of certain functional groups.",
            "Limitation in Source Molecule for Property": "The presence of multiple cyano groups and a potentially rigid bicyclic aromatic moiety may negatively impact the QED score due to balance issues between hydrophobicity, solubility, and molecular complexity.",
            "Optimization for Source Molecule": "To improve the QED score, consider reducing the number of cyano groups or replacing them with functional groups that enhance solubility, such as hydroxyl groups. Simplifying the aromatic systems or modifying the dimethylamino chain to a more flexible structure could also be beneficial.",
            "Final Target Molecule": "CN(C)CCCn1c(N)c(-c2nc3ccccc3s2)c2nc(N)c(C)nc21"
        }
    },
    {
        "src_smiles": "O=C(NCC1CCCO1)C(=Cc1cccc([N+](=O)[O-])c1)NC(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an isoxazoline group, a nitrobenzene moiety, an amide linkage, a cyclohexyl ether, and a secondary amide linkage bound to a phenyl ring.",
            "Property Analysis": "The molecule exhibits moderate complexity with functional groups that may interact with biological targets. The presence of the nitro group can reduce drug-likeness due to potential toxicity, while the phenyl rings and the aliphatic ether may improve hydrophobic interactions with protein targets.",
            "Limitation in Source Molecule for Property": "The nitro group is often associated with toxicity and can decrease the overall drug-likeness of the molecule, negatively impacting the QED property. The molecular weight and presence of several aromatic rings might also pose issues with solubility.",
            "Optimization for Source Molecule": "To improve the QED property, consider replacing the nitro group with a less toxic, electron-withdrawing group like a cyano or trifluoromethyl group. Simplifying the structure by reducing aromatic ring count or introducing more polar functional groups could also enhance solubility and drug-likeness.",
            "Final Target Molecule": "O=C(NCC1CCCO1)C(=Cc1cccc(C#N)c1)NC(=O)c1ccccc1"
        }
    },
    {
        "src_smiles": "O=C(C=Cc1ccc(CCNC(=O)c2ccc3c(c2)OCO3)cc1)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an aromatic ring system with various functional groups, including an amide linkage, an oxime group, and a dioxolane ring.",
            "Property Analysis": "The drug-likeness (QED) property measures how similar a molecule is to known drugs. The current structure may have issues with metabolic stability and membrane permeability due to the presence of multiple polar functional groups.",
            "Limitation in Source Molecule for Property": "The oxime and dioxolane functionalities might be contributing to an increase in polar surface area, leading to reduced drug-likeness. The multiple aromatic rings could also affect solubility.",
            "Optimization for Source Molecule": "To improve QED, consider reducing the number of polar functional groups, such as converting the oxime to a carbonyl group, and potentially simplifying the dioxolane ring to improve metabolic stability.",
            "Final Target Molecule": "O=C(C=Cc1ccc(CCNC(=O)c2ccc3c(c2)C=O)cc1)N"
        }
    },
    {
        "src_smiles": "CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)C(C)(C)C(=O)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is N,N-dimethylacrylamide derivative containing an aromatic ring, an amide linkage, and a hydroxamic acid group. The presence of bulky groups could affect molecule's drug-likeness.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) is a measure for how likely a compound is to be a viable drug candidate based on multiple physicochemical properties like molecular weight, lipophilicity, and presence of specific functional groups.",
            "Limitation in Source Molecule for Property": "The presence of bulky tertiary butyl groups and low polar surface area could unfavorably influence the QED property.",
            "Optimization for Source Molecule": "Reducing steric bulk by simplifying the side chain and introducing more hydrophilic components can improve the molecule's balance between lipophilicity and aqueous solubility.",
            "Final Target Molecule": "CNC(=O)C(Cc1ccccc1)NC(=O)C(C)C(=O)NO"
        }
    },
    {
        "src_smiles": "COc1cc(C=C(C#N)c2ccccn2)ccc1OCc1ccccc1Cl",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is composed of a methoxyphenyl ring, a cyano group with a vinyl linkage to a pyridine ring, an ether linkage to another phenyl ring, and a chlorophenyl group.",
            "Property Analysis": "The source molecule likely has moderate hydrophobicity due to the presence of aromatic rings and could have some degree of polarity from the ether and cyano groups.",
            "Limitation in Source Molecule for Property": "The molecule might have limited drug-likeness (QED) due to its relatively high molecular weight and potential lack of balance between lipophilicity and hydrophilicity.",
            "Optimization for Source Molecule": "To improve the QED, reduce the size by removing or substituting bulky groups with smaller ones while introducing functional groups that improve solubility or metabolic stability, such as adding more polar groups.",
            "Final Target Molecule": "COc1ccc(C=Cc2ccccn2)cc1OC"
        }
    },
    {
        "src_smiles": "C=CCn1c(=O)c2[nH]c(Cc3ccc(N)cc3)nc2n(CCCC)c1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a heterocyclic compound featuring a pyrazolopyrimidine core with additional aromatic and alkyl substituents.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) score may be impacted by the molecule's size, its aromaticity, presence of polar groups, and the synthetic accessibility. The molecule's multiple aromatic rings and heteroatoms might contribute positively, but the alkyl chain and overall complexity might reduce its QED.",
            "Limitation in Source Molecule for Property": "The presence of the long alkyl chain may decrease solubility and synthetic accessibility, reducing the overall drug-likeness score. Additionally, the molecule may have too high a molecular weight and too many hydrophobic areas.",
            "Optimization for Source Molecule": "To improve the QED, consider reducing the length of the alkyl chain at the n-position of the pyrazolopyrimidine core and increasing the proportion of hydrophilic groups or simplifying the structure to decrease molecular weight.",
            "Final Target Molecule": "C=CCn1c(=O)c2[nH]c(Cc3ccc(N)cc3)nc2n(C)C1=O"
        }
    },
    {
        "src_smiles": "CCC1(CC)C(=O)N(COC(=O)c2ccccc2)C1S(=O)(=O)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a core piperidine ring substituted with a sulfonamide group, an ester linkage, and a benzene ring. The presence of multiple aromatic rings and functional groups suggests complexity in its chemical structure.",
            "Property Analysis": "The source molecule has a moderate complexity due to its substituents and conformational flexibilities, impacting its solubility and permeability characteristics. This complexity might be affecting its drug-likeness as measured by QED.",
            "Limitation in Source Molecule for Property": "The bulky sulfonamide substituent and ester linkage increase the molecular weight and potentially reduce bioavailability, thus negatively influencing the QED value. Additionally, the lipophilicity might be high due to the multiple benzene rings, which can also affect drug-likeness.",
            "Optimization for Source Molecule": "To enhance QED, consider reducing molecular weight and lipophilicity by substituting or removing some bulky groups, such as the sulfonamide linkage, or by replacing an aromatic ring with a heterocycle containing nitrogen or oxygen to increase polarity while retaining activity.",
            "Final Target Molecule": "CCN1C(COC(=O)c2ccnoc2)C(=O)C1"
        }
    },
    {
        "src_smiles": "Nc1ccc(-c2nnc(NC(=O)Nc3ccc(Cl)c(Cl)c3)s2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a para-substituted aniline attached to a 1,2,4-triazole moiety that is further connected to a benzamide with two chlorine substituents.",
            "Property Analysis": "The molecule is expected to have reasonable stability due to the aromatic rings and potential interactions through hydrogen bonding and pi-stacking. However, the presence of multiple aromatic rings and chlorine atoms can affect drug-likeness.",
            "Limitation in Source Molecule for Property": "The bulky functional groups and chlorine atoms may increase the molecular weight and reduce solubility, negatively impacting the QED property.",
            "Optimization for Source Molecule": "To improve drug-likeness, reduce the bulkiness by replacing chlorine atoms with less sterically hindering groups and consider simplifying the linker to improve solubility and reduce molecular weight.",
            "Final Target Molecule": "Nc1ccc(cc1)-c2nnc(NC(=O)Nc3ccccc3)s2"
        }
    },
    {
        "src_smiles": "COc1cc(N)c(C=Cc2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-]",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an aromatic compound with methoxy and nitro substituents. It features a methoxy-benzene moiety linked to a nitrophenyl group via a vinyl linkage.",
            "Property Analysis": "The QED property or drug-likeness is moderate due to aromaticity and the presence of functional groups like nitro, which might reduce the drug-likeness score.",
            "Limitation in Source Molecule for Property": "The presence of the nitro group may negatively impact the metabolic stability and overall drug-likeness. Additionally, multiple methoxy groups can increase lipophilicity, potentially affecting solubility.",
            "Optimization for Source Molecule": "To improve the QED, replace the nitro group with a less electron-withdrawing group that maintains hydrogen bonding capability or replace it with a more drug-compatible functional group such as a hydroxyl or amine group. Alternatively, reduce one methoxy group to lower lipophilicity.",
            "Final Target Molecule": "COc1cc(N)c(C=Cc2cc(OC)c(OC)c(O)c2)cc1"
        }
    },
    {
        "src_smiles": "Cc1ccc(SCCC(=O)Nc2ccc(OCc3ccccc3)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is composed of a benzene ring substituted with a thioether group (SCCC(=O)N-) connected to an amide linkage, followed by another benzene ring substituted with a methoxy and benzyl ether group.",
            "Property Analysis": "The QED (Quantitative Estimate of Drug-likeness) assesses features such as the balance of hydrophobicity, molecular weight, and the presence of functional groups known to affect bioavailability and metabolic stability.",
            "Limitation in Source Molecule for Property": "The presence of the thioether linkage and potentially high molecular weight due to the benzyl ether group could lead to decreased drug-likeness by impacting solubility and metabolic stability.",
            "Optimization for Source Molecule": "To improve QED, consider replacing the thioether linkage with a more metabolically stable ether or ester link and potentially reducing the size and lipophilicity of the benzyl ether moiety.",
            "Final Target Molecule": "Cc1ccc(COC(=O)Nc2ccc(OC)cc2)cc1"
        }
    },
    {
        "src_smiles": "C=CCNC(=O)NC(=O)CN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex cyclic urea with two benzene rings, known as a barbiturate derivative. It also contains multiple amide groups along with alkene and amine functional groups.",
            "Property Analysis": "The molecule features multiple functional groups that can participate in hydrogen bonding. However, its complexity and the presence of unsubstituted aromatic rings may hinder its QED property due to increased molecular weight and potential lipophilicity.",
            "Limitation in Source Molecule for Property": "The presence of large and bulky phenyl groups may contribute to high molecular weight and lipophilicity, which could detract from QED, suggesting potential optimization in size and hydrophobicity.",
            "Optimization for Source Molecule": "To enhance the QED property, consider replacing one or both phenyl groups with smaller, less hydrophobic rings or groups that maintain interaction capabilities. Another approach is replacing one carbonyl group with an ether linkage to reduce polarity and size.",
            "Final Target Molecule": "C=CCNC(=O)NC(=O)CN1C(=O)NC(C2=CNC=N2)(c2ccccc2)C1=O"
        }
    },
    {
        "src_smiles": "O=C(CCCCCC(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12)NO",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a ketone with a long carbon chain and two identical indole groups attached. The structure is a secondary amide and nitroso compound.",
            "Property Analysis": "The QED property, or quantitative estimate of drug-likeness, is often reduced by high molecular weight, large size, and presence of non-simple ring systems which complicate bioavailability.",
            "Limitation in Source Molecule for Property": "The source molecule is likely limited by its large size, high molecular weight, and the complexity of the two indole groups, which could negatively impact its drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, reducing molecular size and simplifying the structure could be beneficial. This might involve removing or modifying one of the indole groups and reducing the carbon chain length.",
            "Final Target Molecule": "O=C(CC(c1ccncc1)c1ccncc1)NO"
        }
    },
    {
        "src_smiles": "Cc1ccc(NC(=O)C(=Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2ccccc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an anilide derivative featuring a nitrobenzenoid moiety and an amide linkage. It consists of a central amide bond connecting two benzene rings, with one ring bearing a nitro group and the other methyl substituted.",
            "Property Analysis": "Quantitative Estimate of Drug-likeness (QED) is influenced by the molecule's physicochemical properties such as molecular weight, lipophilicity (logP), number of hydrogen bond donors and acceptors, and structural complexity. The presence of a nitro group may negatively influence the QED due to potential toxicity and low drug-likeness.",
            "Limitation in Source Molecule for Property": "The nitro group is often associated with poor pharmacokinetic properties and can adversely impact the QED score. The molecule's high molecular weight and aromaticity may also limit its drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, consider reducing molecular weight and aromaticity by replacing the nitro group with a less polar, more hydrophobic substituent, such as a methoxy group. Simplifying the structure by reducing aromatic ring count or size might also be beneficial.",
            "Final Target Molecule": "Cc1ccc(NC(=O)C(=Cc2ccc(OC)cc2)NC(=O)c2ccccc2)cc1"
        }
    },
    {
        "src_smiles": "Cc1cc2c(c(=O)o1)C=C1CCC(C(C)CSc3ncccn3)CC1O2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a derivative of a bicyclic lactone structure fused with a cyclohexene, attached to a thiazole moiety through a propyl chain. It has stereocenters and multiple functional groups including a methylthio fragment attached to a pyridine group.",
            "Property Analysis": "The methylthio-pyridine and lactone functionalities may contribute to the molecule's overall rigidity and polarity. The extended conjugated system also influences the drug-likeness; however, steric bulkiness and flexibility might be limiting its effectiveness.",
            "Limitation in Source Molecule for Property": "The bulky thiazole and pyridine might reduce oral bioavailability. The rigidity can enhance binding but may reduce solubility or permeability, and the presence of multiple aromatic systems could lead to metabolic instability.",
            "Optimization for Source Molecule": "Simplify the structure by removing or substituting less relevant bulky groups that contribute less to binding. Introduce hydroxyl or amine groups to improve solubility and permeability. Maintain crucial pharmacophoric elements and stereochemistry to retain target affinity.",
            "Final Target Molecule": "CC1=CC2=C(C(=O)O1)C=CC3(CCOC(C)CNC4=N)CC2CO3"
        }
    },
    {
        "src_smiles": "O=C1CC(N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)C(=O)N1c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a piperazine derivative with two carbonyl groups, linking a benzamide unit. It contains a nitro group on a benzene ring attached to the piperazine.",
            "Property Analysis": "The drug-likeness or Quantitative Estimate of Drug-likeness (QED) is influenced by several factors including molecular weight, hydrogen bond donors and acceptors, lipophilicity (LogP), and the number of rotatable bonds.",
            "Limitation in Source Molecule for Property": "The presence of a nitro group may negatively impact drug-likeness due to potential toxicity and poor metabolic stability. Additionally, the structure may have moderate lipophilicity and several rotatable bonds, affecting the QED score.",
            "Optimization for Source Molecule": "To improve the QED, consider replacing the nitro group with a less toxic group, such as an amine or hydroxyl group, which can enhance solubility and lower molecular weight. Additionally, simplifying the molecular structure to reduce rotatable bonds could be beneficial.",
            "Final Target Molecule": "O=C1CC(N2CCN(c3ccc(O)cc3)CC2)C(=O)N1c1ccccc1"
        }
    },
    {
        "src_smiles": "COc1ccc(C=C(C)C(=O)c2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-]",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a nitrophenyl group attached to a methoxy-phenylpropene moiety, with three additional methoxy groups at the para positions on the phenyl ring.",
            "Property Analysis": "The molecule has a moderate molecular weight and several functional groups that could contribute to its activity and solubility, such as methoxy groups. However, the presence of a nitro group can negatively impact drug-likeness by affecting solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The nitro group is typically considered undesirable in drug design due to its potential toxicity and metabolic instability, which may limit the QED property. Additionally, the high degree of methoxylation can sometimes reduce solubility and cell permeability.",
            "Optimization for Source Molecule": "To improve QED, we can replace the nitro group with a less reactive and more biocompatible group such as a cyano or amino group. Furthermore, reducing the number of methoxy groups on one ring could improve the balance between hydrophilicity and lipophilicity.",
            "Final Target Molecule": "COc1ccc(C=C(C)C(=O)c2ccoc2)cc1C#N"
        }
    },
    {
        "src_smiles": "COc1ccc(Cl)cc1C(=O)NCCc1ccc(CCC(=O)NO)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxyphenyl group, a chlorophenyl amide moiety, and a propionamide group with an additional carbamate functionality.",
            "Property Analysis": "The source molecule likely has a QED value that could be improved with reductions in molecular weight, hydrophobic groups, or steric bulk to enhance drug-likeness.",
            "Limitation in Source Molecule for Property": "The relatively large molecular size, presence of chlorine which may increase hydrophobicity, and multiple functional groups that might not all be necessary could limit QED.",
            "Optimization for Source Molecule": "Reduce molecular weight and hydrophobicity by removing the chlorine atom and potentially simplifying the propionamide moiety. Retain or replace functional groups to balance hydrophilicity and reduce steric hindrance.",
            "Final Target Molecule": "COc1ccc(C(=O)NCCc2ccc(C=O)cc2)cc1"
        }
    },
    {
        "src_smiles": "O=C(Oc1cc(O)c2c(c1)OC(c1ccc(O)cc1)CC2=O)c1cccs1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a polycyclic compound with an ester group (O=C(Oc1)), a thiophene ring (c1cccs1), and phenolic groups (c1cc(O)c2) attached to a chromanone structure.",
            "Property Analysis": "The presence of aromatic rings and an ester functional group generally supports drug-likeness, but the overall QED (Quantitative Estimate of Drug-likeness) may be hindered by the large and complex structure, possibly affecting solubility and permeability.",
            "Limitation in Source Molecule for Property": "The molecule may suffer from excessive size and complexity, which can negatively impact key drug-like properties such as solubility and bioavailability. The presence of multiple aromatic rings and a thiophene, while contributing to stability, might also increase hydrophobicity.",
            "Optimization for Source Molecule": "To improve QED, consider reducing molecular complexity by removing or simplifying the polycyclic structure. Streamline the aromatic systems and potentially replace the thiophene with a more polar group to enhance solubility and overall drug-likeness.",
            "Final Target Molecule": "O=C(Oc1c(O)cc(O)c2c1C=O)ccc1"
        }
    },
    {
        "src_smiles": "Nc1cnc(-c2ccc(-c3ccccc3CSc3ccncn3)cc2F)cn1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an aromatic heterocyclic compound with a fusion of a pyrimidine and a naphthalene-like structure. It contains functional groups such as amines, ether linkages, and heteroaromatic rings.",
            "Property Analysis": "The source molecule has a reasonable balance between hydrophobic and hydrophilic regions, which is beneficial for permeability and solubility. However, the molecular weight and complexity may slightly reduce its drug-likeness according to QED calculations.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings increases the molecular weight and possibly reduces the synthetic accessibility, which can negatively impact the overall QED score. Highly polar groups are limited, which could affect solubility.",
            "Optimization for Source Molecule": "Reducing aromatic ring complexity by removing non-essential aromatic systems may improve QED. Introducing slightly more polar groups may also enhance solubility while maintaining hydrophobic balance.",
            "Final Target Molecule": "Nc1cnc(-c2ccc(-c3ccccc3C(CO)Sc3ccncn3)cc2)cn1"
        }
    },
    {
        "src_smiles": "CCOc1ccccc1NS(=O)(=O)c1cc(-c2cnc(C3CC3)o2)ccc1C",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an ethoxy group attached to a substituted benzene ring. The benzene ring is further connected to a sulfonamide group, which is linked to another aromatic region containing a pyran fused with a cyclopropyl group.",
            "Property Analysis": "The current structure contains aromatic rings and heteroatoms that contribute to molecular complexity, affecting the molecular weight and lipophilicity positively for drug-likeness. However, the presence of multiple aromatic systems and bulky groups may impact solubility adversely.",
            "Limitation in Source Molecule for Property": "Bulky structures and multiple aromatic rings may hinder solubility and permeability. The ethoxy group may not be optimal for balancing hydrophilic and lipophilic properties, impacting the overall QED.",
            "Optimization for Source Molecule": "To improve QED, reduce molecular weight and complexity by replacing bulky groups with smaller, less complex moieties. Consider replacing the ethoxy group with a hydroxyl group and reducing the overall aromatic count by eliminating unnecessary rings.",
            "Final Target Molecule": "Cc1cc(CC2CC2)no1-c1ccc(N)cc1"
        }
    },
    {
        "src_smiles": "COc1ccc(C(=O)Nc2ccc(-c3nc4ncccc4[nH]3)cc2)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a methoxyphenyl urea derivative with a terminal indole moiety. The presence of methoxy groups suggests lipophilicity, and the indole group can impart planarity and possible bioactivity.",
            "Property Analysis": "QED (Quantitative Estimate of Drug-likeness) is influenced by the balance of hydrophobic and hydrophilic groups, molecular weight, polar surface area, and the number of rotatable bonds.",
            "Limitation in Source Molecule for Property": "The molecule has multiple aromatic rings and possibly high molecular weight, which may impact drug-likeness negatively. The methoxy groups may contribute to hydrophilicity inadequately in this structure.",
            "Optimization for Source Molecule": "To improve the QED property, reduce molecular complexity and weight by removing or replacing bulky groups. Replacing the methoxy groups with smaller or more hydrophilic groups like hydroxyl may increase solubility and drug-likeness.",
            "Final Target Molecule": "Cc1ccc(C(=O)Nc2ccc(-c3nc4ncccc4[nH]3)cc2)cc1"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccnc(F)c1)c1ccc(-c2noc(C(F)(F)F)n2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a benzamide moiety connected to a fluoropyridine ring and a trifluoromethyl-substituted oxazole, making it a complex heteroaromatic compound.",
            "Property Analysis": "QED (Quantitative Estimate of Drug-likeness) considers several factors including molecular weight, lipophilicity (LogP), topological polar surface area (TPSA), and the presence of certain structural motifs that enhance drug-likeness such as hydrogen bond acceptors/donors and rotatable bonds.",
            "Limitation in Source Molecule for Property": "The presence of multiple fluorine atoms may increase hydrophobicity excessively and the overall size and structure complexity of the molecule may lower its QED score. Additionally, the rigidity introduced by the oxazole and pyridine rings could hamper bioavailability.",
            "Optimization for Source Molecule": "To improve the QED property, consider reducing the number of fluorine atoms to decrease overall lipophilicity. Introduce structural changes, such as adding a methoxy or hydroxyl group on the aromatic ring, to increase hydrogen bonding potential and possibly lower molecular weight.",
            "Final Target Molecule": "O=C(Nc1ccnc(O)c1)c1ccc(-c2noc(CF)n2)cc1"
        }
    },
    {
        "src_smiles": "O=C(CSc1cccc[n+]1[O-])Nc1ccccc1Oc1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is composed of a thiophene ring bonded to a benzamide. The average molecular weight and presence of a nitro group suggest moderate complexity. The presence of multiple aromatic rings may contribute to planarity.",
            "Property Analysis": "Quantitative Estimate of Drug-likeness (QED) provides scores between 0 (low drug-likeness) and 1 (high drug-likeness). For this molecule, factors such as the presence of multiple aromatic rings and a nitro group can affect QED negatively, due to potential poor solubility and reactivity.",
            "Limitation in Source Molecule for Property": "Nitro groups can decrease drug-likeness due to their reactivity and potential toxicity. The size and aromatic character may also pose solubility challenges, affecting the QED.",
            "Optimization for Source Molecule": "Replace the nitro group with a less reactive and more drug-like functionality such as an amine or sulfonamide group. Consider reducing aromatic ring count or improving water solubility via introducing polar substituents.",
            "Final Target Molecule": "O=C(CSc1cccc[nH]1)Nc1ccccc1Oc1ccccc1"
        }
    },
    {
        "src_smiles": "CCCCOC(=O)c1ccc(NC(=O)C2(c3cccs3)CCOCC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an ester with an aromatic ring containing an amide linkage. It has a butoxy side chain and a polycyclic structure with a thiophene ring.",
            "Property Analysis": "The drug-likeness or QED is influenced by factors such as molecular weight, lipophilicity, polarity, and the presence of certain functional groups.",
            "Limitation in Source Molecule for Property": "The source molecule may have limitations in terms of excessive molecular weight and complexity, which can negatively impact QED. The diversity of functional groups and rings may also affect its bioavailability.",
            "Optimization for Source Molecule": "To optimize for QED, reduce molecular complexity and lipophilicity, potentially by removing or altering large non-aromatic side chains or simplifying polycyclic structures.",
            "Final Target Molecule": "CCCOC(=O)c1ccc(NC(=O)C2CCOCC2)cc1"
        }
    },
    {
        "src_smiles": "COC(=O)C1=C(C)N=C(C)C(=C(O)OC)C1c1ccc(Cl)c([N+](=O)[O-])c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an ester derivative with a nitro group and chlorine on an aromatic ring, which might influence its drug-likeness due to possible toxicity concerns and limited metabolic stability.",
            "Property Analysis": "The QED property or drug-likeness is potentially impacted by the presence of the nitro group, which might decrease the overall hydrogen bond acceptor/donor balance and increase potential toxicity.",
            "Limitation in Source Molecule for Property": "The presence of the nitro group and the ester functionality might negatively impact the drug-likeness due to potential metabolic instability and toxicity.",
            "Optimization for Source Molecule": "Consider replacing the nitro group with a less toxic bioisostere and adjust the ester group to potentially a more stable ether group to improve metabolic stability.",
            "Final Target Molecule": "COC1=C(C)N=C(C)C(=C(O)OC)C1c1ccc(Cl)c(OC)c1"
        }
    },
    {
        "src_smiles": "CC(NC(=O)Nc1cc2[nH]nc(NC(C)c3ccccn3)c2cn1)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex organic compound containing an amide linkage and a triazole ring. It also includes an aniline moiety and a pyridine ring, indicating multiple aromatic systems and potential hydrogen bond donors and acceptors.",
            "Property Analysis": "The molecule appears to have several features common in drug-like compounds, such as aromatic systems and hydrogen bond donors/acceptors, which are beneficial for binding interactions. However, there might be concerns around its size and complexity, impacting membrane permeability and oral bioavailability.",
            "Limitation in Source Molecule for Property": "One limitation affecting the QED property could be the molecule's size and number of aromatic rings, which may affect solubility. Additionally, the pyridine and aniline components might introduce metabolic instability issues due to potential deamination.",
            "Optimization for Source Molecule": "To improve the QED score, we can reduce the molecular size and rigidity. This might be achieved by simplifying the structure, such as removing one of the aromatic systems or potentially replacing it with an aliphatic chain to maintain balance. Additionally, reducing the number of hydrogen bond donors/acceptors can assist in improving drug-likeness and oral bioavailability.",
            "Final Target Molecule": "CC(NC(=O)Nc1cc[nH]nc1)c1ccccc1"
        }
    },
    {
        "src_smiles": "COc1ccc(NC(=O)COc2ccc(C(=O)Nc3cccc(F)c3)c3ccccc23)cc1OC",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a diaryl ether with additional methoxy groups on the benzene rings. It contains amide linkages, aromatic phenyl rings, and a fluorine atom.",
            "Property Analysis": "The source molecule is reasonably drug-like, attributed to its aromatic structure, presence of polar functional groups, and overall molecular weight. However, its QED might be limited due to the presence of multiple aromatic rings and potential for metabolic instability.",
            "Limitation in Source Molecule for Property": "High aromatic content might limit solubility and bioavailability. The molecule may be too large or have limited flexibility, impacting its ability to fit into biological targets. Additionally, the methoxy groups might contribute to higher lipophilicity, potentially reducing oral bioavailability.",
            "Optimization for Source Molecule": "To improve QED, consider reducing aromaticity by replacing one phenyl group with a simpler aliphatic or heterocyclic ring. Simplify methoxy groups or replace them with hydroxyl groups to improve solubility. Introduce a more flexible linker or remove redundant ring systems to optimize the molecule's fit and interaction with biological targets.",
            "Final Target Molecule": "COc1ccc(NC(=O)COc2ccnc(C(=O)Nc3cccc(F)c3)c2)cc1O"
        }
    },
    {
        "src_smiles": "Cc1cc(O)cc(C)c1CC(N)C(=O)N1Cc2ccccc2CC1C(=O)Nc1nn[nH]n1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex structure with several functional groups including hydroxyl groups, amide bonds, and a bicyclic system connected to a pyrazole ring.",
            "Property Analysis": "The Quantum Estimate of Drug-likeness (QED) considers several factors such as molecular weight, lipophilicity, solubility, and the presence of certain chemical groups. The source molecule has high molecular complexity and multiple aromatic rings which might affect its QED value by increasing lipophilicity and molecular weight.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings and a relatively large molecular structure might contribute to lower solubility and increased molecular weight, affecting the QED negatively.",
            "Optimization for Source Molecule": "To improve the QED, potential strategies include reducing the size or number of aromatic rings and eliminating or substituting certain bulky groups to enhance solubility and reduce molecular weight while maintaining necessary pharmacophores for biological activity.",
            "Final Target Molecule": "Cc1cc(O)cc(C)c1CC(N)C(=O)N1Cc2ccc(N)cc2C1"
        }
    },
    {
        "src_smiles": "CC(CCCNc1ccccc1)N(c1cc(Cl)ccc1CO)S(=O)(=O)c1ccc(Cl)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a tertiary amine, a biphenyl structure, sulfamoyl moiety, and chloro-substituted phenyl rings.",
            "Property Analysis": "The molecule has moderate aromatic content, which can contribute to drug-likeness but may also affect solubility. The chloro groups add lipophilicity but can have ambiguous effects on drug properties. The sulfonamide group can enhance water solubility and binding affinity.",
            "Limitation in Source Molecule for Property": "The presence of two chlorine atoms enhances lipophilicity, potentially reducing solubility. The bulky biphenyl structure can affect the molecule's ability to fit into target binding sites, impacting its drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, consider removing one or both chlorine atoms to reduce lipophilicity and enhance solubility while maintaining drug-like features. Substituting the chloro groups with slightly polar, small groups or hydrogen may improve drug-likeness.",
            "Final Target Molecule": "CC(CCCNc1ccccc1)N(c1ccccc1CO)S(=O)(=O)c1ccc(O)cc1"
        }
    },
    {
        "src_smiles": "O=C(CCl)Nc1ccc(N2CCN(CC(O)(Cn3cncn3)c3ccc(F)cc3F)CC2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a urea linkage attached to a di-substituted phenyl ring, which is further connected to a piperazine ring with a bis-fluorophenyl moiety.",
            "Property Analysis": "The QED property, or quantitative estimate of drug-likeness, can be affected by factors such as molecular weight, hydrophobicity, solubility, and the presence of specific functional groups affecting metabolic stability.",
            "Limitation in Source Molecule for Property": "The presence of the large bifluorinated phenyl group and the potentially polar urea linkage in conjunction with the tertiary amine may result in suboptimal balance between hydrophilicity and lipophilicity, which could negatively impact QED.",
            "Optimization for Source Molecule": "To improve QED, consider reducing the size of bulky aromatic groups or replacing them with less fluorinated versions, and potentially modulating the linker region to achieve a better balance of polar and non-polar regions.",
            "Final Target Molecule": "O=C(CCl)Nc1ccc(N2CCN(CC)CC2)cc1"
        }
    },
    {
        "src_smiles": "CC1=C(CC(=O)OCCCCO)c2cc(F)ccc2C1=Cc1ccc(S(C)(=O)=O)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a substituted naphthalene derivative with a carboxylic acid chain and a sulfonyl group. It contains aromatic rings, a fluoro substituent, and multiple functional groups which may complicate its drug-likeness due to mixed polarity and steric bulk.",
            "Property Analysis": "The QED property assesses the drug-likeness based on factors such as molecular weight, lipophilicity, solubility, and the presence of specific functional groups. The source molecule has a complex structure that might affect solubility and permeability negatively.",
            "Limitation in Source Molecule for Property": "The presence of the sulfonyl and ester groups, along with multiple aromatic rings, might contribute to poor solubility and high molecular weight, reducing its QED score. The fluoro and bulky groups can also impact the overall balance between hydrophilicity and lipophilicity.",
            "Optimization for Source Molecule": "To improve drug-likeness, consider simplifying the structure by reducing the number of aromatic rings or bulky groups. Remove or modify polar groups that contribute to low solubility while maintaining a balance to ensure sufficient hydrophilicity for drug activity.",
            "Final Target Molecule": "CC(C(=O)O)C1=CC=CC=C1"
        }
    },
    {
        "src_smiles": "Nc1cnc(-c2ccc(C3CCC3)c(OCC(O)CNc3cc(N)ncn3)c2F)cn1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a pyrimidine core with an amine group, a pyridine fused to an imidazole ring with a substituted aminopentane chain, a phenyl group with a cyclopropyl attached, a methoxyethyl group, and a fluoro substituent. The molecular complexity and the presence of polar functional groups suggest potential challenges in balancing lipophilicity and solubility.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) is an assessment of how drug-like a compound is, based on factors like molecular weight, lipophilicity, solubility, and the number of hydrogen bond donors and acceptors. The source molecule may have suboptimal QED due to high molecular weight, potential synthetic inaccessibility, and multiple polar groups affecting lipophilicity.",
            "Limitation in Source Molecule for Property": "The main limitations affecting the QED are the somewhat excessive molecular weight and the presence of multiple functional groups which might affect lipophilicity and synthesis complexity. High polar surface area due to numerous polar groups can adversely affect permeability and oral bioavailability.",
            "Optimization for Source Molecule": "Consider simplifying the structure to reduce molecular weight and optimize balance between hydrophilic and hydrophobic moieties. Potential optimizations include removing the cyclopropyl group for hydrophobicity reduction, decreasing the number of hydrogen bond donors, possibly by modifying the aminopentane structure, and exploring less polar alternatives for the methoxyethyl group.",
            "Final Target Molecule": "Nc1cnc(-c2ccc(C)c(OCC)cn1)cn1"
        }
    },
    {
        "src_smiles": "COc1cccc(C(=O)Nc2ccc(-c3ccc(S(=O)(=O)NC(C(=O)O)C(C)C)cc3)cc2)c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex aromatic compound with a methoxyphenyl group, an amide linkage, a sulfonamide group, and a carboxylic acid moiety. These functional groups are connected in a way that forms a potentially drug-like structure, as it contains multiple aromatic systems and several hydrogen bond donors and acceptors.",
            "Property Analysis": "The molecule has multiple functional groups that could influence its QED property. The aromatic rings contribute to hydrophobic interactions, the amide and sulfonamide groups provide hydrogen bonding capabilities, and the carboxylic acid imparts polarity. These are beneficial features for drug-likeness, but the overall size and complexity could limit solubility and permeability.",
            "Limitation in Source Molecule for Property": "The source molecule might have limited solubility due to its high molecular weight and the presence of several aromatic rings. The combination of hydrophobic and highly polar functional groups can also lead to poor pharmacokinetic properties. Furthermore, the presence of the carboxylic acid could negatively impact cell membrane permeability.",
            "Optimization for Source Molecule": "To enhance QED, simplify the structure by reducing the number of aromatic rings and consider replacing the carboxylic acid with a less polar group to balance the overall hydrophilicity and lipophilicity. Replacing the methoxy group with a smaller electron-withdrawing group could also potentially improve drug-likeness.",
            "Final Target Molecule": "COc1cccc(C(=O)Nc2ccc(-c3cc(NC(C(F)(F)F)C)ccc3)cc2)c1"
        }
    },
    {
        "src_smiles": "NS(=O)(=O)c1ccc(Nc2nccc(-c3ccc(NC(=O)Cc4cccs4)cc3)n2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an aromatic sulfonamide with three aromatic rings, a thiophene ring, and several heteroatoms including nitrogen, sulfur, and oxygen.",
            "Property Analysis": "The molecule possesses features typical for potential drug candidates such as aromaticity, heterocyclic rings, and hydrogen bond donors/acceptors, but the overall complexity may affect its drug-likeness.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings and sulfonamide may limit solubility and hence potentially lower the drug-likeness score.",
            "Optimization for Source Molecule": "Reduce the aromaticity burden by removing one or more rings or simplifying the structure. Modifying the sulfonamide while preserving the necessary pharmacophores may improve both solubility and drug-likeness.",
            "Final Target Molecule": "NS(=O)(=O)c1cccc(NC(=O)Cc2cccs2)c1"
        }
    },
    {
        "src_smiles": "Cc1oc(=O)oc1COC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an ester and ether derivative featuring a benzene ring with chloro and ketone substitutions. It also contains a lactone ring, a tertiary ester group, and a methylene bridge linking further ester functionalities.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) evaluates properties like molecular weight, lipophilicity, solubility, hydrogen bonding potential, and structural complexity. The source molecule\u2019s complex structure with multiple ester groups and an aromatic chloro ketone might affect drug-likeness.",
            "Limitation in Source Molecule for Property": "High molecular weight, potential steric hindrance from bulky groups, and multiple ester functionalities can affect solubility and permeability negatively, reducing overall QED.",
            "Optimization for Source Molecule": "To improve QED, consider reducing molecular size by removing or replacing bulky groups. Decrease the number of ester linkages or simplify the aromatic substitutions to improve solubility and permeability.",
            "Final Target Molecule": "CC(=O)Oc1ccccc1"
        }
    },
    {
        "src_smiles": "Cc1c(NC(=O)c2ccc(S(=O)(=O)Nc3ccccc3F)cc2)c(=O)n(-c2ccccc2)n1C",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex organic compound containing a benzimidazole core, a benzene ring with a sulfonamide substituent, and a tertiary amine group. It also has a fluorinated phenyl group as part of a sulfonamide linkage.",
            "Property Analysis": "The source molecule contains aromatic rings, a fluorine atom, and a sulfonamide moiety, all of which are considered features that can contribute to favorable drug-like properties, such as good bioavailability. However, the overall complexity and molecular weight may limit its drug-likeness as measured by QED.",
            "Limitation in Source Molecule for Property": "The source molecule may have limitations in terms of molecular flexibility and potential steric hindrance due to its large size and multiple aromatic rings, which can affect its absorption and distribution. Additionally, the presence of multiple polar functional groups may impact lipid solubility.",
            "Optimization for Source Molecule": "To improve the QED property, reduce molecular weight and improve solubility by simplifying some of the aromatic or polar substituents without compromising essential interactions. Consider replacing one of the phenyl rings with a smaller heterocycle or reducing unnecessary substituents while preserving key pharmacophores.",
            "Final Target Molecule": "Cc1n(C)c(=O)c2ccc(S(=O)(=O)Nc3cccnc3)cc2n1"
        }
    },
    {
        "src_smiles": "CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2cc([N+](=O)[O-])cn2C)CC1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex heterocyclic compound with multiple functional groups, including piperazine, nitro, and carboxylic acid groups. The presence of these groups may impact its solubility and overall drug-likeness.",
            "Property Analysis": "The QED property, or Quantitative Estimate of Drug-likeness, assesses the balance of molecular properties typically associated with marketed oral drugs. The source molecule contains aromatic rings and a basic nitrogen atom, which can positively contribute to the QED. However, the presence of the nitro group and carboxylic acid could result in lower QED scores.",
            "Limitation in Source Molecule for Property": "The nitro group and the carboxylic acid group can reduce the QED. The nitro group may be associated with potential toxicity, and the carboxylic acid can influence physicochemical properties such as acidity and solubility but may negatively affect lipophilicity and permeability.",
            "Optimization for Source Molecule": "To improve QED, consider replacing the nitro group with a less polar or non-toxic group such as a methoxy or methyl group. Modifying the carboxylic acid group into an ester or an amide may enhance drug-likeness by improving membrane permeability and reducing acidity.",
            "Final Target Molecule": "CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)OC)cn3-c2cc(C)cn2C)CC1"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccccc1C(=O)N1CCOCC1)c1ccc(CSc2ccccc2)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a benzamide derivative with an acetamide linkage, containing a piperazine ring and a sulfanylbenzene moiety.",
            "Property Analysis": "The molecule has moderate lipophilicity, balanced hydrogen bond donors and acceptors, and multiple aromatic systems contributing to stability and binding potential.",
            "Limitation in Source Molecule for Property": "The presence of the piperazine ring may lead to increased flexibility, reducing interactions with biological targets and impacting drug-likeness.",
            "Optimization for Source Molecule": "To improve QED, introduce a polar group or reduce excessive flexible linkages. Consider transforming the piperazine ring to a more rigid, bioisosteric structure to maintain necessary pharmacophore interactions while enhancing drug-likeness.",
            "Final Target Molecule": "O=C(Nc1ccccc1C(=O)N1C=CCOCC1)c1ccc(CSc2ccccc2)cc1"
        }
    },
    {
        "src_smiles": "CN(C(=O)c1ccc(-c2nc(C3CCOCC3)cnc2N)cc1F)C(CO)c1ccccc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a primary amide linked to an aromatic ring substituted with a fluorine atom and a heterocyclic moiety. It also includes a tertiary amine connecting a substituent aromatic ring with an alcohol group and a methoxymethyl group.",
            "Property Analysis": "The molecule possesses a complex structure with multiple functional groups, offering opportunities for interaction with biological targets, which is favorable for drug-likeness. Potential issues include size, hydrophobicity, and metabolic stability due to the presence of multiple aromatic systems.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings may increase the molecular weight and hydrophobicity, potentially reducing solubility and permeability. The presence of a tertiary amine might also affect metabolic stability.",
            "Optimization for Source Molecule": "To improve QED, consider reducing molecular weight by simplifying aromatic systems or removing heavy atoms that do not contribute significantly to binding affinity. Also, optimize LogP by adjusting the balance between hydrophilic and hydrophobic parts.",
            "Final Target Molecule": "CN(C(=O)c1cc(-c2nc(C3COCC3)cnc2N)ccc1F)C(C)O"
        }
    },
    {
        "src_smiles": "CC(Sc1ncccn1)C(=O)Nc1ncc(Cc2cccc3ccccc23)s1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex organic compound with a thioamide moiety and an aromatic system comprising fused aromatic rings. The SMILES string reveals the presence of multiple heteroatoms in the form of sulfur and nitrogen, along with aromatic substructures indicating potential hydrogen bond acceptor and donor sites.",
            "Property Analysis": "The Quantitative Estimate of Drug-likeness (QED) is a measure that combines several molecular properties relating to drug-likeness, including molecular weight, lipophilicity (LogP), number of hydrogen bond donors and acceptors, and overall molecular flexibility and complexity. The current source molecule likely has moderate to low QED due to its high molecular weight, potential high lipophilicity, and complexity in its structure.",
            "Limitation in Source Molecule for Property": "The source molecule's high molecular weight and complex aromatic structure contribute to a lower QED score. The fused aromatic rings and additional sulfur and nitrogen atoms increase the complexity and potentially the lipophilicity, which can negatively impact drug-likeness.",
            "Optimization for Source Molecule": "To improve the QED, the source molecule can be optimized by reducing the molecular weight and increasing the balance between lipophilicity and hydrophilicity. This can be done by simplifying or removing some of the aromatic rings and reducing the number of heteroatoms if possible, while maintaining essential pharmacophoric groups relevant to activity.",
            "Final Target Molecule": "CC(SC1=NC=CC=C1)C(=O)N"
        }
    },
    {
        "src_smiles": "CCCCOC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is an ester with a quinazoline moiety, substituted with a chloro-phenyl ring and an alkoxy side chain. It also contains a tetrazole ring, indicating potential bioactivity and complexity.",
            "Property Analysis": "The molecule shows features typical for drug-like properties, such as having a heterocyclic core and aromatic substituents. However, the complexity and bulky nature might affect the solubility and permeability negatively.",
            "Limitation in Source Molecule for Property": "The bulky ester side chain may reduce drug-likeness by affecting oral availability. Additionally, highly polar or charged groups such as the tetrazole might reduce membrane permeability.",
            "Optimization for Source Molecule": "To improve the QED property, simplify the ester side chain to reduce molecular weight and polarity. Substitute the chloro-phenyl ring with a simpler hydrophobic moiety, and consider reducing the number of heteroatoms to enhance lipophilicity.",
            "Final Target Molecule": "CCCNC(=O)Cc1cc2c(cc1)nc(n1cnn(C)c1)n2"
        }
    },
    {
        "src_smiles": "Cc1cc(C#N)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2Cc2cc(N)nc(F)c2F)c1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is composed of a naphthalene-like bicyclic aromatic core with various functional groups attached, including nitrile, carbonyl, amide, and fluoro-substituted pyrimidine moieties.",
            "Property Analysis": "The molecule may have good binding interactions due to its aromatic systems and polar functional groups, and moderate lipophilicity. However, its drug-likeness (QED) can be reduced by size, polar surface area, and potential metabolic instability.",
            "Limitation in Source Molecule for Property": "Large size and high number of aromatic rings may negatively impact solubility and metabolic stability. The presence of multiple polar groups might impair permeability, leading to reduced QED.",
            "Optimization for Source Molecule": "To improve QED, reduce excessive molecular weight and aromatic ring count while maintaining key pharmacophores. Simplify the structure by converting complex substituents to smaller bioisosteres and optimize the balance of lipophilicity versus polarity.",
            "Final Target Molecule": "Cc1cc(C#N)cc(C(=O)CC2CCN(C)C(=O)N2)c1"
        }
    },
    {
        "src_smiles": "O=C(C=Cc1ccco1)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of multiple amide bonds and aromatic rings, including a phenyl and a pyridine ring. It has a carboxylic acid functional group at the terminal end.",
            "Property Analysis": "The current structure may have suboptimal lipophilicity and solubility due to extensive aromaticity and amide bonds that might reduce the QED score.",
            "Limitation in Source Molecule for Property": "The presence of multiple aromatic rings and amide bonds contributes to a high molecular weight and potential for low solubility, negatively affecting its drug-likeness (QED).",
            "Optimization for Source Molecule": "To improve QED, reduce molecular complexity by removing or substituting some aromatic rings with less bulky groups. Modify functional groups to improve solubility, such as converting the terminal carboxylic acid to an ester or introducing heterocycles to replace aromatic rings.",
            "Final Target Molecule": "O=C(CN1CCOCC1)NC(C)C(=O)O"
        }
    },
    {
        "src_smiles": "CC(C)C(NS(=O)(=O)c1ccc(-c2ccc(COc3cccc(F)c3)cc2)cc1)C(=O)O",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex structure containing an aromatic sulfonamide attached to a secondary amine linked to a sec-butyl group and an aromatic ester. The molecule features a fluorobenzene ether group, suggesting multiple aromatic interactions.",
            "Property Analysis": "The source molecule's QED value may be influenced by its molecular weight, polar surface area, and aromaticity. The molecule is aromatic-rich but may be moderately high in molecular weight, impacting its drug-likeness.",
            "Limitation in Source Molecule for Property": "Potential high molecular weight and multiple aromatic rings may impede drug-likeness. The presence of a sulfonamide and ester functionality might affect metabolic stability and result in reduced QED values.",
            "Optimization for Source Molecule": "To improve QED, consider simplifying the structure by reducing aromatic ring count or replacing bulky groups, such as the fluorobenzene ether, with smaller alkyl or heteroaromatic substituents.",
            "Final Target Molecule": "CC(C)C(NS(=O)(=O)c1ccc(-c2ccncc2)cc1)C(=O)N"
        }
    },
    {
        "src_smiles": "Cc1ccc(NC(=O)CN2C(=O)SC(=Cc3ccc(-c4ccc(Cl)c(C(=O)O)c4)o3)C2=O)cc1",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a complex organic compound featuring a benzamide linkage, amide group, multiple aromatic rings, and a thiazole moiety. The structure includes functional groups such as methoxy, chloro, and carboxylic acid, indicating a potential for a diverse range of interactions with biological targets.",
            "Property Analysis": "The molecule may exhibit poor drug-likeness due to the presence of multiple polar functional groups, a high molecular weight, and possible poor solubility. The clogP value may be suboptimal due to the balance of hydrophobic and hydrophilic moieties.",
            "Limitation in Source Molecule for Property": "One significant limitation is the high molecular weight and complex structure which may affect its bioavailability and solubility. The presence of a chloro group may also introduce metabolic instability.",
            "Optimization for Source Molecule": "To improve QED, the structure could be simplified by removing excess aromaticity to reduce molecular weight. Opting for less polar substituents could improve solubility. Removing or modifying the chloro-substituted phenyl group could enhance metabolic stability.",
            "Final Target Molecule": "Cc1ccc(NC(=O)C)cc1"
        }
    },
    {
        "src_smiles": "CNC(=O)N(C)CC(O)CN1C2CCC1CC(NC(=O)c1cc3ccccc3n(C(C)C)c1=O)C2",
        "prop": "qed",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a tertiary amide, secondary amine, phenyl ring, and several alicyclic structures, including a bicyclic moiety.",
            "Property Analysis": "The molecule has a moderate molecular weight and the presence of polar functional groups that could be good for aqueous solubility. The tertiary amide and secondary amine groups can affect hydrogen bonding capabilities.",
            "Limitation in Source Molecule for Property": "The relatively large size and complex structure with multiple alicyclic rings might reduce its permeability and bioavailability, potentially affecting the QED property.",
            "Optimization for Source Molecule": "To improve drug-likeness (QED), reducing molecular weight and synthetic complexity by replacing alicyclic structures with simpler structures or optimizing the aromatic moiety for better bioavailability might be considered.",
            "Final Target Molecule": "CN(C)C(=O)CCC1=CC=CC=C1NC(=O)C2=CC=CC=N2"
        }
    }
]